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Abstract
The mechanism by which antigens are processed and presented to T cells exerts a
powerful influence on all immune responses, including those directed against
pathogens. Knowledge of the peptides produced by antigen presenting cells for
presentation to T cells is important in understanding why individuals have different
abilities to combat infection and may prove critical in the design of new vaccines.
The aim of this project was to attempt to use a novel metabolic labelling technique to
enable biochemical identification of potential T cell epitopes in bacterial antigens.
The technique is based upon labelling antigens with the stable isotope carbon-13, and
subsequent identification of antigen-derived peptides using mass spectrometric
isotopic composition analysis. The ultimate goal of the work was to pulse antigen
presenting cells with labelled bacteria and identify MHC class II-associated bacteria-
derived peptides with the objective of identifying potential vaccine candidates.
Towards this goal, outer membrane proteins were prepared and analysed by
polyacrylamide gel electrophoresis and immunoblotted with serum from healthy
individuals. The results showed that the serum antibodies bound to a number of
outer membrane proteins, confirming that they contained B cell epitopes. As a first
step to demonstrate that the outer membrane proteins also contained T cell epitopes,
it was shown that whole bacteria and bacterial antigens can be successfully labelled
with carbon-13 such that all derived peptide fragments may be distinguished by
isotopic analysis. However, due to the complexity of the peptide mixture generated
by a tryptic digest of the outer membrane proteins, it was critical to combine isotope
analysis with excellent chromatographic resolution in order to identify carbon-13
labelled peptides. To address this problem, a new high sensitivity 2D nanoflow liquid
chromatography system was developed and its capabilities compared with
conventional ID reverse phase chromatographic techniques. Two dimensional
separation prior to mass spectral analysis substantially improved the separation of
complex biological mixtures leading to an improvement in the identification of
carbon-13 labelled peptides in such mixtures.
Two dimensional chromatography and carbon-13 labelling was then applied
to investigate the processing of tetanus toxin C fragment (TTCF) by lysosomes
isolated from EBV transformed B lymphoblastoid cell lines. Whilst large TTCF
XV
fragments were demonstrably generated during processing, small (<3kd) peptides
suitable for binding to MHC class II molecules were extremely scarce. Further
experiments suggested that this was unlikely to be a consequence of insufficient
sensitivity of the carbon-13 technique, but probably a consequence of rapid
destruction of the smaller fragments by lysosomal enzymes and high stability of the
larger digestion fragments of TTCF.
It was concluded from these studies that the metabolic labelling of bacterial
proteins with carbon-13 is applicable to the analysis of processed products of
bacterial antigens in complex peptide mixtures. Small peptides, with sizes in the
range bound to MHC class II molecules, appear to be very sparse in processing
compartments, presumably because of rapid proteolysis. Peptides bound to MHC
class II are known to be relatively resistant to proteolysis so in future work it is
proposed to examine TTCF-derived peptides bound to MHC class II molecules rather
than free within lysosomes.
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1. Introduction
T lymphocytes are cells of the immune system that orchestrate the cell-
mediated arm of the acquired immune response. This includes the protective immune
responses generated against pathogens and cancer cells, and the disease causing
responses that cause autoimmune disease. Both CD4+ and CD8+ T cells recognise
protein antigens in the form of 'processed' antigen derived peptides 'presented' on
the surface of antigen presenting cells bound to MHC molecules (Unanue 1984;
Townsend and Bodmer 1989). The activation of CD4+ and CD8+ T cells is the result
of the two separate pathways within cells (figure 1.1) known as the MHC class I and
MHC class II processing pathways (Pamer and Cresswell 1998; Pieters 2000).
Activation of T cells by peptides presented by the relevant pathway leads to the most
appropriate immune response for clearance of viral and bacterial pathogens.
CD8+ T cells recognise peptides bound to MHC class I molecules which are
constitutively expressed at the surface of the majority of nucleated cells. This may
reflect the fact that every cell within the body is susceptible to infection. Peptides
feeding into this pathway are derived from cytosolic proteins that have been digested
in the cytoplasm by a structure called the proteasome. These peptides are
subsequently transported into the endoplasmic reticulum (ER) by the transporter
associated with antigen processing (TAP) and loaded onto class I molecules for
display at the cell surface to CD8+ T cells. During infection, viral proteins and those
derived from intracellular bacteria (e.g. Listeria monocytogenes) feed into this
pathway (reviewed in Pamer and Cresswell 1998).
CD4+ T cells recognise peptides bound to MHC class II molecules that are
constitutively expressed on the surface of dendritic cells, macrophages, and B cells.
These cells also express the appropriate co-stimulation required to activate T cells
and are thus termed 'professional antigen presenting cells'. During infection, class II
expression can also be induced upon other cell types such as epithelial cells by y-
interferon. Thus, a wider range of cells has the ability to act as antigen presenting
cells during an immune response. Peptides feeding into this pathway include those
derived from exogenous proteins internalised into the cell. These proteins are
digested in the endosomal-lysosomal pathway where they are loaded onto MHC
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class II molecules within specialised MHC class II loading compartments (MIIC) for
expression at the cell surface to CD4+ T cells. A minor pathway also exists in which
recycling MHC class II molecules bind to their ligands in early endosomes (reviewed
in Pieters 2000).
The MHC class II pathway is expected to be of more importance in the
processing and presentation of extracellular bacterial antigens. For this reason, the
following section will take a more in depth look at antigen processing and
presentation within the MHC class II pathway. However, it should be noted that
MHC class I molecules can also present peptides derived from exogenous antigens to
CD8+ T cells. This alternative processing pathway for exogenous antigens will be
discussed in section 1.1.8.
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Figure 1.1 MHC class I and class II processing pathways
MHC class I pathway: A) Intracellular antigen is digested into peptides by a
cytosolic structure called the proteasome. B) Peptides released by the proteasome
are transported into the ER by TAP where they bind to MHC class I molecules. C)
MHC class I - peptide complexes travel through the Golgi body and are directed to
the cell surface. D) Surface MHC class I - peptide complexes present peptide to
CD8+ T cells.
MHC class II pathway: A) Extracellular antigen is engulfed into the cell by a form
of endocytosis. B) Early endosomes mature into late endosomes, and eventually fuse
with lysosomes C) Antigen is digested into peptides by proteolytic enzymes D)
MHC class II heterodimers are synthesised in the ER and associate with the
invariant chain to form nonameric complexes (a(3Ii)3. E) These complexes pass
through the Golgi body and are directed to the compartment for peptide loading
(M11C) F) In the MI1C, the invariant chain is removed from the MHC class II
groove in exchange for peptide. G) MHC class II - peptide complexes are
transported to the cell surface where they present peptide to CD4 T cells. H)
Recycling MHC class II molecules from the cell surface may also bind to antigen in
early endosomes.
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1.1 Antigen processing and presentation in the MHC class II pathway
The mechanisms involved in MHC class II presentation of extracellular antigens
are usefully considered as two distinct but overlapping pathways. First is the pathway
taken by extracellular antigen, which includes the key stages of antigen uptake into
the antigen presenting cells and the processing of antigen into peptides suitable for
MHC class II binding. In this pathway, protein antigens are internalised into the cell
by a variety of mechanisms and are subsequently delivered to the endosomal /
lysosomal network for enzymatic degradation. In antigen presenting cells, some
antigen derived peptides may be rescued from proteolytic destruction by
incorporation into MHC class II / peptide complexes, which are subsequently
transported to the cell surface for CD4+ T cell recognition. The second pathway is
that taken by MHC class II molecules from their site of synthesis to the relevant
MHC class II loading compartments. These pathways overlap at several places
providing opportunities for class II molecules to bind antigen-derived peptides. The
following sections will initially follow the pathway taken by antigen engulfed into
antigen presenting cells and will then focus upon the pathway taken by class II
molecules from their site of synthesis to the site of peptide loading within antigen
presenting cells.
1.1.1 Antigen uptake
Antigen uptake is critical for the processing and presentation of the majority
of antigens. The rate at which antigen is internalised is an important determinant of
the efficiency of presentation, with antigen presenting cells being able to utilise
several uptake mechanisms which differ greatly in their specificity, efficiency and
capacity (Lanzavecchia 1996). These uptake mechanisms include both non-specific
(pinocytosis and macropinocytosis) and specific (receptor mediated endocytosis and
phagocytosis) mechanisms. The predominant mechanisms of uptake employed by an
antigen presenting cell influences their contribution towards the development of an
immune response and also the functional outcome.
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1.1.1.1 Fluid phase uptake
Fluid phase antigens that are unable to bind to cell surface receptors may be
internalised non-specifically along with fluid captured by the cell during pinocytosis
(Swanson and Watts 1995). During this process, invaginations of the cell membrane
form, pinch off as pre-endosomal vesicles and rapidly fuse with early endosomes.
The formation of clathrin coated pits commonly precedes pinocytosis, forming
clathrin coated vesicles of between 85-110 nm in diameter. Macropinocytosis is a
distinct mechanism that is best characterised by marked membrane ruffling followed
by the envacuolation of extracellular fluid within large (0.5-5 pm) uncoated vesicles.
Whilst both macrophages and endothelial cells are capable ofmacropinocytosis upon
stimulation, immature DC are the only cells that constitutively carry out
macropinocytosis (West et al., 2000). Macropinocytosis is thought to be an important
mechanism by which bacteria and larger sized particles (>0.5 pm) are engulfed into
immature dendritic cells before they migrate to secondary lymph nodes to generate
an immune response (Xiang et al., 2006).
B cells are very poor at fluid phase uptake, being estimated to pinocytose
extracellular antigen at a 100-1000 fold lower level than macrophages (Chesnut et
al., 1982; Lanzavecchia 1990). As pinocytosis represents the sole mechanism of
uptake for non-specific B cells, these B cells are very inefficient at presenting
antigen to T cells during primary immune responses.
1.1.1.2 Receptor-mediated endocytosis
Both macrophages and dendritic cells express a variety of membrane
receptors that can bind to antigen (e.g. mannose receptor) or to the Fc portion of
circulating immunoglobulins (e.g. FcyR). Like pinocytosis, receptor mediated
endocytosis is commonly characterised by the formation of clathrin coated pits
followed by the formation of pre-endosomal vesicles (Edeling et al., 2006).
However, receptor mediated endocytosis has clear quantitative and qualitative
advantages in comparison to non-specific fluid uptake mechanisms. For example,
antigen specific B cells present antigen to T cells at 100-1000 fold lower antigen
concentrations compared to non-specific B cells (Rock et al., 1984; Lanzavecchia
1985). This is thought to be the result of a concentrating effect upon the surface of
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the antigen presenting cell, leading to faster and more efficient antigen uptake of
much lower levels of soluble antigen (Lanzavecchia 1990). Similarly, mannose
receptor-mediated uptake of antigens results in a approximately 100-fold more
efficient presentation to T cells, as compared to antigens internalized via fluid phase
(Engering et al., 1997). Further evidence to support enhanced immunogenicity
following receptor mediated mechanisms has been provided by the conjugation of
antigens usually internalised by fluid phase pinocytosis to ligands for cell surface
receptors. For example, antigen conjugates targeting surface immunoglobulin
produce equivalent in-vitro T cell responses at 500-1000 fold lower antigen
concentrations and are more immunogenic in vivo (Lakey et al., 1988; Snider and
Segal 1989; Barnes and Mitchell 1995). Similar enhancement has been reported for
conjugates targeting other cell surface receptors including the transferrin receptor
(McCoy et al., 1993), Fey receptors (Gosselin et al., 1992), the a2 microglobulin
mannose receptors (Chu and Pizzo 1993), and the mannose receptor (Sallusto et al.
1995).
In addition to enhancing the immune response, receptor mediated endocytosis
can also influence the functional outcome of an immune response by influencing
epitope production. One proposed mechanism for this is by the preferential targeting
of antigen to different compartments. For example, there is now evidence to suggest
that different components of the B cell receptor complex may target internalised
antigens to different processing compartments. The B cell receptor complex consists
of a surface immunoglobulin (slg) which is associated with an Iga / Ig(3 heterodimer.
It has been shown that the cytoplasmic domains of Iga and lg(3 contain signalling
domains that selectively target ligand - receptor complexes for presentation on newly
synthesised or recycling MHC class II molecules respectively (Bonnerot et al.,
1995). Further experiments demonstrated that the signalling motifs in Iga and IgP
targeted antigens to distinct sub-cellular organelles, leading to the production of
different T cell epitopes (Amigorena and Bonnerot 1998). Similarly, it has been
demonstrated that different Fc receptors lead to the production of different T cell
epitopes from the same antigen that may be the result of antigen delivery to different
processing compartments by different Fc receptors (Amigorena et al. 1998;
Amigorena and Bonnerot 1999). In addition, the mannose receptor recycles
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constitutively between the plasma membrane and early endosomes where it releases
its ligand (Stahl et al., 1980). Thus, the delivery of antigen to different processing
compartments by different receptors or different components of the same receptor
may influence the epitopes produced and thus the outcome of an immune response.
A second mechanism by which receptors may influence the immune response
is by directly interfering with the processing of antigens. This has been demonstrated
most clearly for the B cell receptor. Interference of the B cell receptor following
internalisation of receptor-ligand complexes 'sculpts' antigen processing (Davidson
and Watts 1989; Watts et al., 1998; Antoniou and Watts 2002). This form of epitope
directed processing has been shown to influence the production of T cell epitopes
from tetanus toxin C fragment (TTCF) in a number of B cell lines. The bound
immunoglobulin imparts a 'footprint' upon the antigen, protecting areas from
enzymatic processing and MHC class II binding. Uptake of radiolabeled TTCF into
a number of B cell lines has revealed that different immunoglobulin receptors
'footprinted' different areas of the antigen, leading to the production of different
processing fragments detected using SDS-PAGE. Antibody guided processing has
also been shown to suppress the loading of certain T cell epitopes located within the
footprinted area whilst boosting the presentation of others (Simitsek et al., 1995).
1.1.1.3 Phagocytosis
Phagocytosis is a ligand-induced form of endocytosis by which large particles
such as microbes and tissue debris are engulfed into antigen presenting cells (Brown
1995; Silverstein 1995; Aderem and Underhill 1999). In addition to antigen
presenting cell, other cell types are capable of phagocytosis such as epithelial cells of
the thyroid, bladder and retina (Zeligs and Wollman 1977; de Boer et al., 1996;
Sarangarajan and Apte 2005; Strauss 2005) However, it is only antigen presenting
cells that express a large enough number of receptors to allow them to phagocytose a
wide variety of antigens. For example, they possess receptors for complement
components, LPS in bacterial cell walls, and mannans in yeast wall cells. This allows
them to phagocytose wide range of microbial antigens. Following the binding of
antigen to phagocytes, actin rearrangement leads to the formation of membranous
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extensions called 'pseudopods' which engulf large particles (>0.5 pm) into the cell,
targeting the antigen for destruction in the endocytic pathway.
Both macrophages and immature dendritic cells readily engulf large
particulate antigens by phagocytosis. For instance, macrophages are able to
internalise up to 50% of their cell surface area in one round of phagocytosis
(Steinman et al. 1983). It has been recently shown that a large amount of the
phagosomal membrane is of ER origin, suggesting that the ER and plasma
membranes may fuse together during phagosome formation to compensate for the
vast amounts of membrane used during phagocytosis (Gagnon et al., 2002; Watts
2002; Edeling et al., 2006). In contrast to macrophages and dendritic cells, B cells do
not carry out phagocytosis.
Following internalisation, phagosomes undergo maturation by fusing with
endosomes and lysosomes, to form a phagolysosome that contains a variety of potent
enzymes required for antigen degradation and epitope production (Aderem and
Underhill 1999). There is evidence to suggest that epitopes released following
phagocytosis may be different to those released by non-specific uptake mechanisms.
Von Delwig et al., (2002) demonstrated that phagocytosis of viable Streptococcus
pyogenes by macrophages leads to the production of an epitope from the surface M5
protein (M517-31) that is not produced following uptake by macropinocytosis.
Similarly, uptake by macropinocytosis results in the production of a different epitope
from the surface M5 protein (M5308-319) that is not produced following phagocytosis.
Other results from the group demonstrated that these two epitopes have different
processing requirements and that M517.31 was bound by mature and recycling MHC
class II molecules whereas M5308-319 was bound by newly synthesised MHC class II
molecules (Delvig and Robinson 1998; Delvig and Robinson 1998). It was thus
postulated that Streptococci pyogenes is delivered to different processing
compartments following uptake by these two mechanisms, leading to the generation
of different epitopes. Therefore, the type of uptake mechanism employed by a cell
influences the production of epitopes from an antigen. This may lead to the
generation of a more diverse repertoire of T cell epitopes, thus influencing the
functional outcome of an immune response.
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1.1.2 Antigen processing
Once antigens have been engulfed into antigen presenting cells, they are
degraded into peptide fragments by proteolytic enzymes for MHC class II binding
and subsequent display to T cells (Riese et al., 1996; Riese and Chapman 2000; Turk
et al., 2000; Villadangos and Ploegh 2000; Watts 2001). The acidic environment of
the endocytic pathway is important for the majority of proteolytic enzymes to work
at their optimum, with a decrease in pH from 6.5 to 4.5, being paralleled by increased
enzyme activity and harsher proteolysis.
The decrease in pH also contributes to antigen denaturation and unfolding
which is important in allowing the access of enzymes to their cut sites within the
antigen (Jensen 1993). A second important factor influencing denaturation is the
reduction of disulfide bonds within the antigen. Disulfide bond reduction has been
shown to influence the production of epitopes from several antigens and thus T cell
recognition (Collins et al., 1991; Haque et al., 2001; Marie et al., 2001; Li et al.,
2002). Oxidation of protein antigens is also thought to contribute to antigen
unfolding and to the exposure of epitopes recognised by specific T cells (Carrasco-
Marin et al., 1998).
The traditional view of antigen processing is that enzymes work in a
redundant manner to degrade antigens, with many enzymes being able to carry out
the same role during degradation. To support this idea, analysis of MHC class II
associated peptides revealed that there are no common cleavage sites at the termini of
eluted peptides, indicating that any of the proteases may act if given the opportunity
(Rudensky et al. 1991). In addition, it has been shown in-vivo that mice lacking
several of the enzymes previously thought to be important in antigen processing are
not deficient in antigen processing (Villadangos et al., 1997; Deussing et al., 1998).
However, there is now increasing evidence to suggest that individual enzymes can
play a more important and non-indispensable role in the processing of antigens. The
roles of these enzymes together with others implicated in antigen processing will be
discussed in further detail in the following sections.
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1.1.2.1 Cathepsins
Both cathepsins D and B were originally suggested to play an important role
in antigen processing. This was due to in-vitro studies implicating both of these
enzymes in antigen processing together with the high expression of these enzymes in
antigen presenting cells (Watts 1997). However, it was later revealed that knockout
mice deficient in either of these two enzymes were not deficient in the presentation
of T cell epitopes from antigens, dismissing their earlier role (Villadangos et al.,
1997; Deussing et al., 1998). However, additional studies have once again implicated
these proteases in antigen processing. For example, Driessen et al., (2001)
demonstrated that cathepsin B was a key enzyme in the in-vivo degradation of an
immune complex following Fc y R-mediated uptake in antigen-presenting cells. In
addition, Zhang et al., (2000) demonstrated that the inhibition of cathepsin B in mice
immunized with ovalbumin, modulated the specific immune response from a T
helper 2 (Th2) type towards a TH1 response. It has also been demonstrated that the
processing of exogenous glutamate decarboxylase (GAD) is sensitive to inhibition of
cathepsin D (Lich et al., 2000). Thus, cathepsin B and D almost certainly have an
important role, but are not essential, possibly because other endosomal proteases
have similar specificity.
Both cathepsins S and L have been shown to play a role in antigen
processing. A recent study analysing the MHC peptide repertoire of embryonic
fibroblast lines deficient in either cathepsin S or L reported that epitope generation
for a subset of antigens is specifically regulated by the activity of both of these
enzymes (Hsieh et al., 2002). Another in-vitro study demonstrated that cathepsin S
dominated the processing of myelin basic protein following digestion with lysosoml
extracts isolated from human B lymphoblastoid cells (Beck et al., 2001). Several in-
vivo studies have also shown a role for cathepsin S in antigen processing. Using
cathepsin deficient mice, it was demonstrated that cathepsin S plays an independant
role in the degradation of immune receptor complexes delivered via Fey R into
antigen presenting cells. In a second study, antigen presenting cells failed to present
specific T cell epitopes from hen egg lysosome in cathepsin S deficient mice (Pluger
et al., 2002). Most recently, it was demonstrated that intestinal epithelial cells present
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a class II-bound endogenous peptide to naive CD4 T cells in vivo in a Cat S-
dependent fashion (Beers et al., 2005).
Recently, another member of the cathepsin family has been shown to play a
dominant role in antigen processing. The serine protease cathepsin G plays a critical
role in the in-vitro processing of myelin basic protein (MBP) following digestion
with lysosomes isolated from primary B cells, (Burster et al., 2004). Unlike other
cathepsins, cathepsin G is not endogenously synthesised by human B lymphocytes.
Rather, it is internalised into lysosomes from the plasma membrane where it
subsequently participates in antigen processing. Due to its cell surface expression, it
has been suggested that cathepsin G may also play a role in extracellular antigen
degradation. However, this remains to be elucidated.
1.1.2.2 Asparaginyl endopeptidase
Asparagine endopeptidase (AEP) is a novel cysteine protease that has strict
specificity, cleaving only after accessible asparagine residues in antigens. AEP
activity was first described during experiments showing that AEP is critical in the
initiation of processing of the model antigen, tetanus toxin C fragment (TTCF)
(Manoury et al., 1998). The dominant role of AEP in the digestion of TTCF was the
first example of an enzyme playing a critical non-redundant role in antigen
processing. Using lysosomal extracts isolated from lymphoblastoid B cells, AEP was
shown to be the dominant enzyme in the digestion of TTCF, cleaving after 3
asparagine residues to generate 5 processing products detectable by SDS-PAGE
analysis. Suppression of AEP activity in human B cells was found to inhibit
presentation of TTCF to a number of T cell clones, whilst the pre-processing of
TTCF with AEP accelerated presentation. Further experiments demonstrated that
mutagenesis of the 3 AEP cleavage sites in TTCF together with inhibition of AEP
activity slowed down the kinetics of antigen presentation as well as the subsequent
presentation of a number ofT cell epitopes (Antoniou et al., 2000). Cleavage by AEP
after 1 or 2 asparagine residues in TTCF was responsible for this influence upon
antigen presentation.
As a result of all of these experiments, a model was postulated for the
digestion of TTCF (figure 1.2). In this model, it is hypothesised that an initial
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cleavage by AEP acts to 'unlock' TTCF. Together with denaturation, unlocking of
the antigen in this manner allows other proteases as well as AEP to carry out further
cleavages at hydrophobic sites previously inaccessible to proteolysis. Although AEP
is critical in the unlocking step in TTCF digestion, different enzymes may perform
this initiating step for different antigens. It should be noted, however, that it is not
clear whether all or even most antigens require unlocking prior to digestion. It has
been shown that in AEP deficient mice, presentation to primary T cells of OVA and
myelin oligodendrocyte glycoprotein, two antigens that contain asparagine residues
within or in proximity to the relevant epitopes was unimpaired (Maehr et al., 2005).
Thus, the importance of AEP in the production of T cell epitopes from a wide range
of antigens remains to be elucidated.
In contrast to its action upon TTCF, it has also been shown that AEP action
can be destructive. Studies using the autoantigen myelin basic protein revealed that
AEP activity destroyed a T cell epitope, preventing its display on class II MHC
molecules (Manoury et al., 2002; Watts et al., 2003). This is due to the presence of
an accessible AEP processing site at Asn 94 within the epitope. It has been shown
during in-vitro experiments that the presentation of this self epitope inversely
correlates with the level of AEP. As a consequence, it has been suggested that
destruction of this epitope within the thymus by AEP may prevent the establishment
of T cell tolerance towards this 'cryptic' epitope. Later changes in antigen
processing may result in the presentation of this peptide, leading to the generation of
auto-reactive T cells. For instance, it has been suggested that natural deaminidation
of AEP cut sites in 'ageing' self antigens (e.g. MBP) may lead to the presentation of
previously cryptic epitopes to T cells and thus autoimmune disease (Moss et al.,
2005).
1.1.2.3 y-interferon-inducible lysosomal reductase (GILT)
GILT is an enzyme that is thought to play an important role in disulphide
bond reduction within lysosomes (Arunachalam et al. 2000). Initial experiments
demonstrated that GILT is optimally active between pH 4-5 and is capable of
catalysing the disulphide bond reduction of F(ab)'2 and intact immunoglobulin
during both in-vitro and in-vivo experiments. It was therefore hypothesised that
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GILT may aid in the unfolding of protein antigens in the acidic endocytic
environment. Further experiments demonstrated that disulphide bridge reduction
catalysed by GILT is important in the production of T cell epitopes from protein
antigens (Marie et al., 2001). In GILT free mice, the presentation of two major
epitopes from hen egg lysozyme (HEL) was found to be partially or completely
abrogated, directly implicating this enzyme in disulphide bond cleavage and the
generation of certain T cell epitopes. These results clearly show a non-redundant and
critical role for GILT in the reduction of disulphide bonds in at least some protein
antigens. As a consequence, it has been hypothesised that antigen unfolding in the
presence of GILT aids in the access of both the initiating protease and secondary
proteases to their cut sites (Watts 2001). This would explain the importance ofGILT
in the generation of some T cell epitopes from antigens.
Although GILT plays a key role in the processing of antigens, there may also
be other yet unidentified enzymes involved in endosomal redox reactions. For
example, it has been shown that the action of GILT is not responsible for the
reduction of intrachain disulfide bonds required for the presentation of a H2-Ed-
restricted epitope in the influenza hemagglutinin antigen (Sinnathamby et al., 2004).
Antigen presenting cells (fibroblasts) obtained from GILT-free mice presented the
H2-Ed-restricted epitope, and introduction of GILT had no impact on presentation.
The authors concluded that there might be mechanisms for GILT-independent
reduction in the late endosome.
1.1.2.4 Other enzymes
There is limited information on which other enzymes are thought to play key
roles in the processing of antigens. However, it has been demonstrated that a
mutation in HEL to create a dibasic (lysine-arginine) motif adjacent to a
subdominant determinant (HEL23-32) resulted in a ~10 fold increase in presentation
of the determinant (Schneider et al., 2000). The identity of the enzyme that made this
cleavage is unknown although it was suggested to be a member of the pro-protein
convertases (Seidah and Chretien 1997). In addition, the use of serine and
metalloprotease inhibitors have implicated both these classes of enzymes in early
endosomal processing of antigens and in the generation of certain T cell epitopes
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from antigens (Delvig and Robinson 1998; Musson et al., 2003). Furthermore, the
inhibition of serine proteases has been shown to block the presentation of a number
of epitopes that also require further lysosomal processing before presentation. Thus,
initial processing in early endosomes may be essential prior to further processing
within lysosomes in the production of certain T cell epitopes.
1.1.2.5 MHC guided processing
It has been traditionally assumed that peptides released during antigenic
degradation are rescued from proteolytic destruction by binding to MHC molecules
in specialised endocytic compartments. However, how do peptides survive in this
harsh proteolytic environment long enough for MHC class II molecules to bind? It
has been postulated that this may be because MHC class II molecules protect T cell
epitopes from complete degradation by binding to partially unfolded antigen (Sercarz
et al., 1993; Sercarz and Maverakis 2003). Following the binding of MHC II
molecules, endopeptidases can then act at other processing sites within the antigen
and the bound peptides ultimately trimmed by exopeptidases (e.g. cathepsin B,
cathepsin H).
There is now increasing evidence to support that MHC guided processing
does play a role in the 'sculpting' of antigens during proteolysis. It has been
demonstrated that MHC class II molecules can bind to flexible regions in intact
antigens as well as full-length reduced antigens (Lee et al, 1988; Sette et al., 1989).
In addition, it has been shown that only limited processing of TTCF is required by
AEP before MHC class II binding can occur. Therefore, it is possible that MHC class
II molecules may bind to antigen in endocytic compartments after very little
processing. In support of this, studies have revealed that larger peptides (3000-7000
Da) can be eluted from I-A or I-E murine class II molecules if care is taken
(Castellino et al., 1998). Furthermore, the presence of a long hen egg lysozyme
derived polypeptide was detected bound to two different MHC class molecules (I-Ak
and I-Ek) within the endocytic pathway following the pulsing of antigen presenting
cells with HEL (Germain and Margulies 1993).
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Figure 1.2 Proposed model for digestion of antigens in the endocytic
environment
(A) An initiating protease (e.g. AEP) makes the initial cleavage(s) which acts
to unlock the protein (B) Reduction of disulfide bonds by enzymes such as
GILT aids in antigen unfolding and thus proteolytic digestion (C)
Endopeptidases (e.g. cathepsin D) act together with the initiating protease to
further digest the antigen at previously hidden hydrophobic sites (D) MHC
class II molecules may protect the destruction of epitopes by binding to
regions of the partially unfolded antigen (E) Exopeptidases (e.g. cathepsin
B) trim the MHC class II bound peptides to lengths eluted from the cell
surface shown in (F).
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1.1.3 Structure and function of MHC class II molecules
The structure of MHC molecules, and more specifically the peptide binding
groove, is critical in understanding the basis of peptide binding. The following
section will look at structural differences between MHC class I and II molecules and
how these differences influence the peptides that can bind. It will also briefly discuss
the structural basis of peptide binding and how polygeny and polymorphism in the
MHC leads to different MHC molecules presenting different sets of peptides to T
cells.
1.1.3.1 Genetic organisation of the MHC
The MHC is located on chromosome 6 in humans and on chromosome 17 in
mice. In humans, it extends over ~4 centimorgans ofDNA, consisting of 4 xlO6 base
pairs and more than 200 genes (Beck and Trowsdale 2000). Figure 1.3 shows the
general organisation of the MHC class I and class II genes in both humans and in
mice. The organisation of the MHC complex is similar in both humans and mice,
with genes being organised into class I and class II regions. In humans, the MHC is
termed the Human Leukocyte Antigen (HLA), comprising of genes encoding both
class I molecules called HLA-A, B, C and class II molecules called HLA-DP, DQ
and DR. In mice, the MHC is called the Histocompatibility-2 (H-2) complex. Like in
humans, there are 3 class I genes called H2-K, -D, and -L, and 3 class II genes called
H2-A and -E. Within the MHC class II genes, there are genes encoding DO and DM
molecules that are important in the MHC class II processing pathway and LMP and
TAP molecules that are important in the MHC class I processing pathway. In both
humans and mice, the MHC complex also contains class III genes encoding a
number of proteins important in the immune response including complement
components and cytokines.
1.1.3.1.1 Polygeny and polymorphism within the MHC
The MHC is polygenic with several genes encoding both class I and class II
molecules. In humans, there are three class I a-chain genes (HLA-A, -B, and -C) and
three pairs of MHC class II a and P chain genes (HLA-DR, DP, and DQ). In many
cases, the HLA-DR cluster contains an extra p gene whose product can pair with the
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DR a chain. This means that the three sets of genes give rise to four types ofMHC
class II molecule. All of the MHC molecules encoded by these genes have different
peptide specificities, allowing them to bind to different sets of peptides. As a result
of polygeny, every person will express at least 3 different MHC class I molecules
and 3 different MHC class II molecules at the surface of their antigen presenting
cells. Thus, polygeny increases the chance that peptides generated from a single
antigen will be bound by an MHC molecule and presented to T cells. This is
important for the generation of immune responses against infectious agents on an
individual level.
With the exception of DRA1, the class II loci are also highly polymorphic,
with there being over 200 alleles of some human MHC class I and class II genes
(Robinson et al., 2003; Schreuder et al., 2005). As a result of the polymorphic
nature of the MHC, most individuals are heterozygous at MHC loci, inheriting
different alleles from their parents. Since MHC expression is co-dominant,
individuals may have up to 6 different MHC class I molecules and 8 different MHC
class II molecules. This increases the diversity already available through polygeny at
the individual level. The extensive polymorphism at each locus is also protective at
the community level, with different individuals possessing different MHC molecules
and therefore having differing susceptibility to infection.
Polymorphisms are confined to codons that determine 2 classes of residues in
MHC molecules. The first class of residues are those flanking the pockets within the
peptide binding groove (Babbitt et al., 1985; Babbitt et al., 2005). These residues are
important in peptide binding because they determine which peptides can bind to the
MHC molecule. The second class of residues contribute to parts of the a helices
which contribute to the surface engaged by T cell receptors (Zinkernagel and
Doherty, 1997). Allelic variation thus results in class II molecules with very similar
structures but with different peptide specificities and TCR binding characteristics.
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Figure 1.3 The Major Histocompatibility Complex (MHC) in humans and
mice
The organisation is shown for the principal MHC genes in both (a) humans and (b)
mice. The arrangement of MHC genes is similar in both species, with clusters of
MHC class I, class II, and class III genes being observed. However, in mice, the
MHC class I gene H-2K has translocated relative to the human MHC so that the class I
region in mice is split into two.
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1.1.3.2 Structure ofMHC molecules
MHC molecules are heterodimeric transmembrane glycoproteins that are
expressed at the cell surface. The structures of class I and class II molecules are
shown in figure 1.4. Crystallographic studies have shown that class I and class II
molecules have remarkably similar 3-dimensional structures (Bjorkman et al., 1987;
Brown et al., 1993). Both have an antigen binding groove with a beta pleated sheet
floor bordered on 2 sides by alpha helices. This arrangement allows peptides to be
securely bound with elements of their structure visible to T cells. Despite this broad
similarity, there are important differences between class I and class II molecules
which profoundly influence the peptides they bind.
MHC class I molecules comprise a single transmembrane glycoprotein non-
covalently associated with [12 microglobulin. The class I peptide binding groove is
closed at both ends limiting the sizes of peptides that can stably bind. Interactions
between the amino and carboxyl termini of bound peptides with residues in pockets
at each end of the groove are important for stable binding. Peptides shorter than the
length of the groove (~9 amino acids) bind poorly; peptides longer than this (up to 12
residues) may be accommodated only if the peptide backbone can bulge up out of the
middle of the groove.
MHC class II molecules consist of two non-covalently linked membrane
glycoproteins called the alpha (a) and beta ((3) chains. Both of these are encoded in
the MHC complex and consist of a short cytoplasmic domain and transmembrane
portion, followed by a membrane proximal domain called the a2 and [32 domains
respectively. These are both similar in amino acid sequence and structure to
immunoglobulin constant regions. The membrane proximal domain in each chain is
followed by a membrane distal domain called the al or pi domain, which together
form the peptide-binding groove. Unlike MHC class I molecules, the class II peptide
binding groove is open at both ends, and as a consequence, can accommodate long
peptides that protrude at either side of the binding cleft (Demotz et al., 1989; Chicz
et al., 1993; Rammensee et al., 1993; Falk et al., 1994). Thus, antigen presenting
cells can present a large amount of peptides bound to only a small set of different
class II molecules.
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Structural analysis of the 3-dimensional structure of class II - peptide
complexes has revealed the structural basis of peptide binding (Stem et al., 1994;
Ghosh et al., 1995). Peptides are bound with a 9 amino acid sequence clasped in the
groove. Longer peptides protrude at either or at both ends of the groove. The bound
segment of a peptide is often called the 'core binding sequence' because of its major
importance in the class II / peptide interaction. Peptide / class II interactions, most
important in stabilising the bound peptide, occur between peptide backbone atoms
and conserved residues / main chain atoms in parts of the class II molecules flanking
the peptide binding groove. Thus, binding is stabilised mainly by interactions that are
independent of the bound peptide's sequence.
These binding-favourable interactions depend on the bound peptide adopting
a particular conformation in the groove that requires the peptide's side chain residues
to be accommodated within pockets in the walls of the peptide-binding groove. The
crystal structures obtained for DR1 and DR3 with bound peptide show a very similar
pattern of pockets arranged along the walls and base of the peptide-binding groove.
However, the class II amino acid residues that flank the pockets in the DR1 and DR3
structures are quite different. These residues determine the character of the pockets
(charge, hydrophobicity and size) and hence the ease with which different peptide
side chain residues can be accommodated, placing different constraints on the
sequences of peptides that can be stably bound.
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Figure 1.4 Structure ofMHC class I and class II molecules
MHC class I and class II pioleins are heterodimeric transmembrane glycoproteins.
MHC class I molecules consist of an a chain encoded within the MHC which is non
covalently associated with a P2M molecule encoded outside of the MHC. The a
chain folds into 3 domains, with the al and a.2 domains forming the binding site and
the a3 domain containing a transmembrane domain. In contrast, MHC class II
molecules consist of an a and p chain both encoded within the MHC. The a and p
chain fold into 2 domains each, with the al and pi domains forming the peptide
binding groove and the a2 and P2 domains containing transmembrane anchors.
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1.1.4 MHC class II biosynthesis and trafficking
In order for peptide binding to occur, MHC class II molecules must enter
peptide-containing compartments of the endocytic pathway. MHC class II molecules
are synthesised in the ER and subsequently targeted to class II loading compartments
for peptide binding. To prevent MHC class II molecules from binding to peptides
before their arrival at the relevant class II loading compartments, newly synthesised
MHC class II molecules associate with a type II transmembrane glycoprotein called
the invariant chain (Ii) to form nonameric complexes, (apii)3 (Jones et al., 1979;
Cresswell 1994). This association prevents cytosolic peptides in the ER from binding
to MHC II molecules (Roche and Cresswell 1990; Teyton et al., 1990; Busch et al.
1996). A signalling motif present in the cytoplasmic domain of the invariant chain
acts to target the class II complexes to the appropriate endocytic compartments for
class II binding (Bakke and Dobberstein 1990; Lotteau et al., 1990; Pieters et al.,
1993). These MHC class II - peptide complexes are subsequently transported to the
cell surface for presentation to T cells. Surface class II / peptide complexes are stable
with a turn over rate of many days, but continuously recycle through early
endosomes and a proportion also reaches later endocytic compartments. Thus, class
II molecules are detectable throughout the endocytic system as well as in the ER, the
Golgi and at the cell surface. Identifying the precise route by which class II traffics
between these compartments, and in particular the locations at which peptides are
bound, is still not complete.
The compartment to which newly synthesised MHC class II - invariant chain
complexes are directed may not be identical in all cell types, but in B cells and
dendritic cells most nascent MHC class II — invariant chain complexes rapidly enter a
distinct compartment called the MHC class II compartment or MIIC (Harding 1995).
The MIIC has ultra-structural, enzymatic, and electrophoretic properties distinct from
compartments of the classical endocytic pathway. It has a density similar to late
endosomes but has a distinct multivesicular morphology on electron microscopy and
lacks late endosomal (mannsoe-6-phosphate receptor) and early endosomal
(transferrin receptor) markers (Peters et al., 1991). It also contains molecules which
are important for the formation of class II / peptide complexes. More recently, class
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II loading compartments (CIIV) have been identified as MHC class II rich
compartments in B cells (Amigorena et al., 1994). These differ from MIIC in that
they structurally resemble early endosomes (Pierre and Mellman, 1998). In B cells,
peptide loading can occur in either MIIC or CIIC (Bryant and Ploegh 2004). It is
thought that most nascent MHC molecules reach these endocytic compartments
without visiting the cell surface but the exact route is uncertain. Some MHC class II
- invariant chain complexes are detectable at the cell surface and rapidly recycle into
endosomes (Roche et al. 1993). Recycling MHC class II - invariant chain complexes
and class II / peptide complexes presumably supply the populations of class II in
other endocytic compartments, some of which also contain HLA-DM (Guagliardi et
al., 1990).
1.1.5 Sites of MHC class II maturation and peptide loading
Class II molecules are widely distributed among the intracellular
compartments of antigen presenting cells and can probably bind to peptides at
several locations, the most important depending upon the antigen and cell type
(Castellino and Germain 1995). At least for some antigens, the majority of antigen-
derived peptide / class II molecules are composed of newly synthesised class II
molecules, so the way nascent class II become loaded with peptide in MIIC has been
closely studied in several cell types (Harding 1996).
Following delivery of MHC class II - Ii complexes to the MIIC, the Ii is
degraded by proteases to leave the class II associated peptide (CLIP) within the class
II peptide binding cleft (Blum and Cresswell 1988; Pieters et al, 1991; Chapman
1998). During the maturation of MHC class II molecules, the Ii chain goes through
the intermediate forms lip 22 (MW 22 KDa) and lip 10 (MW 10 KDa) before its
conversion into CLIP. The enzyme AEP has been shown to be one of the enzymes
that can perform the initial conversion of Ii into lip 22 (Manoury et al., 2003).
Cathepsin S plays a critical role in the terminal processing of lip-10 into CLIP in B
cells, dendritic cells, and intestinal epithelial cells (Riese et al., 1996; Nakagawa et
al., 1999; Shi et al., 1999; Beers et al., 2005). Cathepsin L has the same function as
cathepsin S in thymic epithelial cells (Nakagawa et al., 1998).
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The removal of CLIP in exchange for peptide is promoted by the chaperone
HLA-DM (Denzin and Cresswell 1995; Sherman el al. 1995; Sloan et al., 1995). The
MIIC is the compartment with the highest concentration of HLA-DM. However, it
has now been demonstrated that HLA-DM is located throughout the endocytic
pathway. In addition to its critical function in exchanging CLIP for peptide, DM also
functions to catalyse the release of low-stability peptides, allowing high affinity
peptides to ultimately form complexes with MHC class II molecules (Katz et al.,
1996; Weber et al., 1996; Kropshofer et al. 1997). In B cells, DM is regulated by the
chaperone HLA-DO (Liljedahl et al., 1996; Denzin et al., 1997). DO is thought to
inhibit the activity of DM in all but the most acidic late endosomal compartments, to
which the majority of BCR- internalised antigens are targeted. Thus, DO might
promote the presentation of peptides derived from BCR-internalised antigens
(Alfonso et al., 2003; Brocke et al., 2003; Bryant and Ploegh, 2004).
1.1.6 Alternative sites of MHC class II peptide loading
An alternative minor pathway has also emerged, in which mature MHC class
II molecules recycled from the cell surface bind to antigen in early endosomes
(Griffin et al., 1997; Pinet and Long 1998; Robinson and Delvig 2002). The binding
of epitopes to recycled MHC class II molecules is proving critical for the
presentation of a growing number of epitopes, including those derived from HEL,
influenza virus haemagglutinin, myelin basic protein, and tetanus toxin. Recycled
MHC class II molecules may bind to flexible regions within intact antigens or
alternatively following partial unfolding and degradation. It is highly probable that
the epitopes released in early endosomes may be destroyed by harsher proteolysis in
later processing compartments. Indeed, it has been demonstrated that peptides
released by early endosomes from antigens differ from those released in later
processing compartments (Pinet et al., 1994). Thus, the release of different epitopes
in early and late endosomes may give rise to a varied epitope repertoire for T cell
recognition (Watts 1997; Robinson and Delvig 2002). The dependence of peptide
loading in early endosomes upon HLA-DM is unknown, with several epitopes being
shown to be loaded onto recycled class II molecules in a HLA-DM independent
manner.
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In addition to peptide loading within late and early endosomes, there is now
evidence to suggest that MHC class II loading can also occur within the phagosomal
pathway, with class II molecules, invariant chain and HLA-DM all being found in
phagosomes (Ramachandra et al., 1999). It has been shown that phagosomal
compartments contain MHC class II molecules and that purified phagosomes
containing antigen coupled latex beads can activate specific T cell hybridomas
(Ramachandra et al., 1999; Ramachandra and Harding 2000). Further experiments
carried out by the group demonstrated that phagosomal processing and presentation
of antigen-coupled latex beads was dependant primarily on nascent MHC class II
molecules delivered from intracellular sites (e.g. endocytic compartments). Other
groups, however, have demonstrated that the binding of recycled MHC molecules to
peptides in phagosomes is essential for the presentation of a number of epitopes
(Pinet et al., 1994; Cella et al., 1997; Balaji and Boom 1998; Delvig and Robinson
1998; Musson et al., 2002). Despite these results, it is not clear whether the bulk of
peptides released from particulate antigens, bind to MHC class II molecule present
within phagosomes, or are transported into endosomal compartements for MHC
loading (Ramachandra et al., 1999).
1.1.7 MHC Class II associated peptides
Information about the properties of peptides bound to MHC molecules came
from structural determination of the MHC molecules and by the characterisation of
eluted peptides (Rotzschke et al., 1990; Van Bleek and Nathenson 1990; Fremont et
al. 1992; Rammensee et al., 1993). As predicted by crystallographic studies, peptides
eluted from class I molecules were approximately 9 amino acid residues in length
(Bjorkman et al., 1987; Schumacher et al., 1991; Rammensee et al., 1993). The same
techniques later applied to MHC class II elution studies revealed that much longer
peptides of between 15-25 amino acids in length bind to MHC class II molecules,
consistent with the crystal structure (Demotz et al., 1989; Rudensky et al., 1991;
Chicz et al., 1992; Hunt et al., 1992; Riberdy et al., 1992; Chicz et al., 1993;
Newcomb and Cresswell 1993).
In class II elution studies, peptides were derived mostly from self membrane-
associated and endosomal proteins including MHC molecules, invariant chain and
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proteolytic enzymes. A minority derived from exogenous proteins. These are mainly
proteins present in the extracellular fluid at high concentrations (several mg/ml) such
as albumin and haemoglobin, and proteins for which there are very efficient uptake
mechanisms such as apolipoprotein B-100 and transferrin. Analysis ofMHC class II
peptides revealed that MHC class II eluted peptides typically consisted of peptides of
heterogeneous length derived from the same region of the protein. These sets of
peptides were termed 'nested sets' and were found to overlap over at least 12 core
binding residues but differ in length at both the N and C termini, reflecting the
structure of the MHC class II binding groove. Despite the variable lengths of class II
peptides, residues in a 9 amino acid core were shown to be critical for either MHC
binding or TCR contact (Stern et al., 1994; Rammensee 1995; Johansen el al., 1996).
Structural features of peptides facilitating peptide binding to specific MHC
molecules became clear following sequence characterisation ofMHC eluted peptides
and co-crystallisation of MHC molecules bound to peptide (Garrett et al. 1989;
Fremont et al. 1992; Matsumura et al., 1992). This led to the identification of peptide
motifs and anchor residues within peptides eluted from specific class II molecules
(Falk et al., 1991; Falk et al., 1994). Peptide binding motif is the term given to the
common amino acids shared by peptides binding to particular class I and II
molecules with high affinity. They are often termed 'anchor residues' because they
stabilise binding of the peptide inside the groove. Crystallographic studies have
revealed that these anchor residues are accommodated by a number of pockets in the
floor of the binding groove (Garrett et al., 1989; Rammensee et al., 1993; Stern et
al., 1994).
1.1.8 Non-conventional processing pathways of exogenous antigens by
MHC class I molecules
Although the MHC class II processing pathway is considered to be the most
important pathway for the presentation of exogenous antigens, it is now apparent that
exogenous antigens can also enter the conventional MHC class I processing pathway
for presentation to CD8+ T cells in a process called cross presentation (Ackerman and
Cresswell 2004; Trombetta and Mellman 2005). There are a number ofmechanisms
that have been suggested to account for cross presentation including the 'leaking' of
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antigens from endosomes into the cytosol and the delivery of antigens to the ER with
subsequent escape into the cytoplasm. Most recently, it has been suggested that cross
priming may occur as a result of ER incorporation into the phagosomal membrane
during phagocytosis. Analysis of phagosomes revealed that several ER components
including TAP and tapasin might be present in the phagosomal membrane (Garin et
al., 2001; Gagnon et al., 2002). This discovery led to the proposal that during
phagocytosis of bacterial pathogens, incorporation of ER membrane into the
phagosome allows access ofMHC class I molecules and other associated molecules
such as the proteasome to peptide fragments within the phagosome (Watts 2002;
Ackerman and Cresswell 2004).
In addition to conventional class I molecules, the non-classical MHC class I
molecules belonging to the CD1 family are also thought to present peptides derived
from exogenous antigens to CD8+ T cells (Braud et al. 1999; Kerksiek and Pamer
1999; Sugita et al., 2004; Watts 2004). CD1 molecules are MHC-like molecules
which have a non-polymorphic alpha chain encoded outside the MHC. Like classical
MHC class I molecules, the alpha chain associates with P2M. CD1 molecules patrol
the endocytic pathway for lipid antigens that they present to CD8+ T cells. In
humans, there are five CD1 loci (a-e), four of which are expressed, and recycle
through different compartments of the endocytic compartment. The contribution of
these different processing pathways towards immunity in many types of infection is
unclear. However, studies have implicated CD1 molecules in protection against M.
tuberculosis (Porcelli 1995; Stenger et al., 1997; Stenger and Modlin 1998; Braud et
al., 1999; Rosat et al., 1999).
1.2 Identification of naturally processed and presented CD4+T cell
epitopes from exogenous antigens
Knowledge of the peptides selected for presentation to T cells from antigens
and the underlying mechanisms of antigen processing and presentation is critical for
the design of new 'epitope' based vaccines. Several approaches have been employed
to identify or predict CD8+ and CD4+ T cell epitopes in antigens (Walden 1996;
Lauemoller et al., 2000; Schirle et al., 2001). These include T cell mapping
experiments that directly identify T cell epitopes and predictive methods that identify
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peptides that may potentially be T cell epitopes. Predictive methods involve either
the prediction of peptides that will bind to a given MHC allele based upon peptide
motif information or the identification of naturally processed and presented peptides.
With predictive methods, experimental verification is required to confirm that the
peptide is a T cell epitope. This involves the analysis of MHC binding properties
using synthetic peptides and T cell recognition using proliferation assays.
1.2.1 CD4+ T cell mapping studies
One approach to identify epitopes within antigens is to examine T cell
responses of either animals (e.g. mice) or individuals immunised with whole antigen
(reviewed in Walden et al., 1996). This approach usually employs the synthesis of
overlapping peptides that cover the whole sequence of the protein. The peptides are
then tested for their capacity to stimulate T cells that have been isolated from
immunised donors. This technique of using T cells has the advantage that it is
extremely sensitive, with CD4+ T cells being able to detect even a single peptide-
MHC complex on the surface of antigen presenting cells (Krogsgaard et al., 2005).
Experiments using T cells isolated from immunised humans has led to the
identification of a number of 'universal epitopes' in tetanus, diphtheria and
mycobacterial antigens (Diethelm-Okita et al. 1997; Diethelm-Okita et al., 2000; Al-
Attiyah et al., 2003; Caccamo et al., 2004). Universal epitopes are regions of
antigens to which the majority of humans in a population make a T cell response. For
example, >80% of a panel of HLA-diverse individuals immunised with tetanus
toxoid (TTD) had T cells that proliferated to peptide TTD 950-969 (Diethelm-Okita et
al., 2000). In addition, in-vitro T cell responses elicited by universal epitopes have
been shown to be comparable to that of the whole antigen. The identification of these
universal epitopes within an increasing number of antigens means that they could be
included in synthetic epitope based vaccines to generate a protective immune
response. Alternatively, universal epitopes could be used to boost the immune
response to other immunising antigens. However, to date, there have only been a
handful of antigens analysed for human T cell epitopes.
A major drawback in these studies is that they require a large number of
individuals to be immunised with the antigen of interest. This is difficult because
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even modified antigen can be potentially too toxic to risk immunisation of
volunteers. In addition, murine epitopes provide limited information because they
may not necessarily be the same as epitopes presented by their human counterparts
due to differences in MHC molecules and antigen processing between the two
species. In addition, T cell mapping studies provide no information of peptide
flanking residues that are important in peptide binding and T cell activation (Moudgil
etal. 1998).
1.2.2 Prediction of MHC binding
The identification of peptide binding motifs together with the development of
MHC peptide binding algorithms, have permitted the prediction of both CD8+ and
CD4+ T cell epitopes in a number of defined antigens (reviewed in Laumoller et al.,
2000 and Schirle et al., 2001). In order to predict peptide binding motifs for MHC
ligands, several groups have carried out MHC-peptide binding assays (Ruppert et al.,
1993; Hammer et al. 1994; Hammer et al. 1994; Kubo et al. 1994; Parker et al.,
1994). Other groups have identified sequence motifs based upon sequence
information of natural ligands eluted from class II molecules (Falk et al., 1991; Hunt
et al., 1992; Hunt et al., 1992; Corr et al., 1993; DiBrino et al., 1993; Falk et al.,
1994).
Whereas the prediction of T cell epitopes has been successful for CD8+ T
cells, it has had only limited success in identifying epitopes for CD4+ T cells. It is
thought that one reason for this difficulty is the occurrence of class II peptides as
nested sets, with peptide motifs not being confined to the core sequence like class I
peptides (Rudensky et al., 1991; Hunt et al., 1992; Chicz et al., 1993). Thus, bound
peptides are not in register that complicates interpretation of pool sequencing
experiments (Falk et al., 1994; Rammensee 1995). Secondly, class II binding is often
degenerate, with peptide binding motifs providing an incomplete description of the
full diversity of peptides that are able to bind to MHC class II molecules (Panina-
Bordignon et al., 1989; Busch et al., 1990; O'Sullivan et al., 1990; Roche and
Cresswell 1990; O'Sullivan et al., 1991). It is known that peptides with very different
sequences sometimes bind equally well to many different class II molecules.
Analysis of the structure ofDR / peptide complexes has led to the discovery that this
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is because sequence independent interactions alone substantially stabilise class II /
peptide binding (Stern et al., 1994). In addition, positive interactions in some pockets
can overcome negative interactions in others. As a consequence, all peptides have the
potential to bind provided that their peptide side chains can be adequately
accommodated in pockets in the class II groove. In addition, peptides predicted to
bind to specific class II molecules may not be naturally processed and presented. As
a result, it is difficult to predict T cell epitopes from antigens based upon sequence
information alone.
1.2.3 Analysis of naturally processed and presented peptides
In the last 15 years, it has become possible to identify both CD8+ and CD4+T
cell epitopes from antigens of interest by analysing naturally processed and presented
peptides. This approach has the advantage over the other methods of T cell epitope
identification in that it identifies naturally processed and presented peptides that
represent the sum of all the selection events in the production of T cell epitopes. This
is in contrast to predicting MHC class II binders that is based solely upon sequence
information. However, there are also disadvantages in this technique in that it is a
very laborious and time consuming approach and requires vast amounts of raw
materials.
To date, the identification of naturally processed and presented bacterial
derived T cell epitopes following infection has only been described for CD8+ T cells.
The first of these studies identified a naturally processed and presented Listeria
monocytogenes derived murine CD8+ T cell epitope bound by H2-Kd (Pamer et al.,
1991). In this study, mice where experimentally infected with L. monocytogenes, the
splenic material isolated and the MHC class I peptides eluted for purification by
HPLC and detection by CTL targeting activity. Subsequent studies identified 3 more
naturally processed and presented CD8+ T cell epitopes bound by H2-Kd, all ofwhich
were derived from secreted proteins important in L. monocytogenes virulence (Pamer
1994; Sijts et al., 1996; Busch et al., 1997). One of these was biochemically
characterised by partial sequence analysis and database searching (Pamer 1994). A
similar strategy was later used to identify CD8+ T cell epitopes derived from
M. tuberculosis (Flyer et al., 2002). In this study, cell lines were experimentally
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infected with M. tuberculosis and the MHC class I molecules isolated. Mass
spectrometric sequencing ofMHC class I isolated peptides led to the identification of
three CD8+ T cells from the same mycobacterial antigen.
The identification of bacterial derived CD4+ T cells following experimental
infection has proved difficult. One reason is because antigenic peptides of interest
eluted from MHC class II molecules occur in very small amounts amongst the
heterogeneous sea of peptides eluted from class II molecules (Sanderson et al.,
1995). This complex mixture makes the purification of antigenic peptides by HPLC a
difficult task. In addition, the occurrence of class II peptides as nested sets
complicates analysis. Fractionation of class II associated peptides leads to the
dilution of individual class II peptides, with individual members of a nested set being
eluted into different fractions.
A more common strategy in the identification of CD4+ T cell epitopes has
been to pulse large numbers of antigen presenting cells with huge amounts of antigen
and subsequently analyse peptides eluted from the HLA molecule of interest using
biochemical techniques. In theory, any antigen can be analysed in this manner and
naturally processed and presented peptides bound by any MHC class II molecule
studied. The first biochemical success was reported in 1992 when Nelson et al.
identified several HEL-derived peptides amongst I-Ak associated peptides. Since this
study, there have only been seven more successes to date that are summarised in
table 1.1 (Nelson et al., 1992; Vignali et al., 1993; Phelps et al., 1996; Peakman et
al., 1999; Nepom et al., 2001; Kaliyaperumal et al., 2002; Dengjel et al., 2004;
Meiring et al., 2005). The majority of these studies have analysed peptides derived
from antigens implicated in the development of auto-immune disease bound to
human DR molecules expressed by lymphoblastoid B cell lines. Typically, these
studies have used in the order of 1010 cells and milligrams of antigen for success.
However, the most recent report analysed peptides derived from the meningococcal
outer membrane protein Por A presented by primary human dendritic cells. In this
study, only 106 antigen presenting cells were required for successful identification of
several T cell epitopes. This reduction in the number of antigen presenting cells is
probably due to advancements in biochemical techniques over the past decade.
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Biochemical advancements will be discussed together with the problems still faced in
these studies in the following section.
Year Authors Antigen / MHC
molecule/ APC




HEL / IAKI murine B
cells
• Identification by subtractive
methods using HPLC tracings
- Characterisation by Edman pool
sequencing of fractions containing
antigen derived peptides and mass
matching to HEL sequence
1993 Vignali et al. HEL / IAK / murine B
cells
• Identification by testing the ability
of individual HPLC fractions to
stimulate T cell hybridomas
■ Characterisation by MALDI-MS
analysis of stimulatory fractions
and mass matching
1996 Phelps et al. a3 (IV) / DR15 / EBVB
cells
• Identification by subtractive
methods using MADLI-MS
• Characterisation by mass
matching to a3 (IV)/ sequence
1999 Peakman
etal.
IA-2 / DR4 / EBV B cells ■ Identification by subtractive
methods using MALDI-MS
• Characterisation by MS/MS
analysis of 'extra' antigen derived
peptides and mass matching
2001 Nepom et al. GAD65 expressing DR4
/ EBV B cells
• Identification and characterisation
by online nano-flow RP-LC-MS
followed by MS/MS analysis of all
peptides and mass matching
2002 Kaliyaperumal
etal.
Chromatin / A20 / EBV
B cells
• Identification by stimulation of T
helper clones with HPLC fractions
• Characterisation by MS/MS
analysis of active fractions and
mass matching
2004 Dengjel etal. Cyclin D1 / HLA-DR4 /
EBV B cells
• Identification by subtractive
methods using MALDI-TOF MS
• Characterisation by MS/MS
analysis and mass matching
2005 Meiring etal. Meningococcal porin A
1DR1 / human dendritic
cells
• Identification by online nano-flow
RP-LC-MS to identify 15N labelled
peptides
• Characterisation by MS/MS
analysis and mass matching
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Table 1.1 Reported biochemical successes in the identification of T helper
cell epitopes in exogenous antigens
The table shows the 8 published accounts of identification and characterisation
of CD4+ T cell epitopes from exogenous antigens. Methods of characterisation
include Edman sequencing, mass matching and most recently, mass
spectrometric sequencing (MS/MS) using tandem mass spectrometry. In order to
reduce the number of peptides to be characterised, groups have either used
subtractive methods or the testing of HPLC fractions with T cell clones /
hybridomas for their stimulatory capacity.
1.2.3.1 Problems currently faced in biochemical studies
Problems in biochemical studies have arisen due to the complexity of
peptides eluted from class II molecules and due to limitations in the sensitivity of
sequencing analysis. Vignali et al., (1993) estimated that individual antigen derived
peptides represent less than 1% of the total peptide pool isolated from MHC class II
molecules which typically consists of thousands of peptides. As a consequence, the
main problems have been (i) identifying peptides of interest within the complex
peptide pool eluted from MHC class II molecules and (ii) being able to characterise
extremely small amounts of these peptides. In the first published success, Nelson et
al., (1992) used Edman degradation to sequence peptides that at the time required
approximately 10 pmoles of pure peptides for success. This study utilised 80g of
HEL in 80 litres of supernatant containing 1010 cells and was successful due to the
dominance of certain antigen derived peptides that permitted their sequencing despite
partial purification. However, in subsequent studies carried out by Vignali et al.,
(1993) and Phelps et al., (1996), peptides were present at very small amounts and
were therefore unable to be sequenced. In both these cases, peptides were
characterised by mass matching.
However, recent advancements in mass spectrometry have largely overcome
the problem of sequencing, with modern day mass spectrometers being able to detect
sub-femtomole amounts of sample (Lemmel and Stevanovic 2003). These tandem
mass spectrometers provide MS/MS data that permits the partial sequence analysis of
peptides of interest. Peakman et al., (1999) was the first group to use MS/MS
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sequencing to characterise antigen derived peptides, with sensitivity of analysis being
estimated to be at the femtomolar level. Since this study, there have been further
advancements in sensitivity, with Nepom et al., (2001) sequencing a peptide
estimated to occupy only 10 MHC class II molecules per cell on the 107 cells
analysed (-1.7 attomoles) by nanospray-Fourier transform mass spectrometry. These
advances in mass spectrometric sensitivity have substantially eroded the former
principal hurdle in MHC peptide analysis of peptide characterisation. As a
consequence, identifying peptides of interest within the complex peptide pool for
sequence analysis remains the major problem.
One solution has been to identity T cell epitopes within the complex peptide
pool without fractionation (Nepom et al., 2001; Meiring et al., 2005). This has been
made possible by the recent development of highly sensitive mass spectrometers.
However, this method is time consuming and it is very expensive to generate
sequence information for all peptides eluted from class II molecules. Alternative
strategies have been to reduce the complexity of class II peptides and thus simplify
the identification of potential T cell epitopes. In the first approach, T cells have been
used to identify fractions in which epitopes are present by testing the stimulatory
capacity of each fraction (Vignali et al., 1993; Kaliyaperumal et al., 2002). In these
studies, the use of T cells reduced the problem to identifying a few peptides in a
hundred rather than a few peptides in thousands. In the second approach, subtractive
methods are employed in which comparisons of MHC class II peptides eluted from
both sham pulsed and antigen pulsed antigen presenting cells are made to identify
extra 'putative' peptides (Nelson et al., 1992; Phelps et al., 1996; Peakman et al.,
1999; Dengjel et al., 2004). Nelson et al., (1992) identified major HEL derived
epitopes by comparing the UV tracings from both antigen and sham pulsed cells.
This was made possible by the abundance ofHEL derived peptides. However, in all
other reports, only minor differences have been observed in the overall UV profiles
obtained from antigen pulsed and control cells. This complexity is illustrated in
figure 1.5 which shows UV tracings obtained from the study carried out by Phelps et
al., (1996) in the identification of naturally processed and presented peptides derived
from the type IV collagen chain in the a3 antigen (a3 (IV)). As a result of the
complexity of class II peptides following fractionation, MALDI-TOF MS was
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employed in this study and others to identify antigen derived peptides. Mass
spectrometric analysis has shown that up to 100 peptides can typically elute in one
HPLC fraction, making analysis very time consuming and difficult when trying to
identify the scarce antigen derived peptides by subtractive methods.
Clearly, it would be ofmajor advantage in both of these methods to be able to
unambiguously identify antigen-derived peptides in complex peptide mixtures.
Conventional protein labelling techniques used in antigen processing studies have
included radioactive labelling as well as discrete labels such as biotin and colloidal
gold. However, these labelling techniques have limited utility when applied to
tracing proteins through environments in which protein degradation occurs, such as
through the antigen processing system of antigen presenting cells. This is because
discrete labels are introduced at a limited density, so may not be contained within
important fragments. Moreover, the labelling process usually modifies specific
amino acids with potential effects upon biological activity, such as binding to class II
molecules. Metabolic labelling, usually with radioactive isotopes, overcomes the
deficiencies of discrete labels. However, it has the disadvantages of being potentially
hazardous, and difficult to control in large scale experiments required to generate
sufficient peptide for biochemical analysis.
The use of stable isotopes in protein labelling overcomes the deficiencies of
both radioactive and discrete labels and will be discussed in the following section.
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Comparison of mass spectrograms of HPLC
fraction 23a and corresponding control fractions
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Figure 1.5 Identification of naturally processed and presented peptides from
o3 (IV)
(a) Shows a UV spectrogram of a RP HPLC separation ofMHC class II peptides
from a3 (IV) pulsed and sham pulsed cells. The tracing is extremely complex with
only minor differences being observable, (b) Mass spectrograms of Fr 23 from the
HPLC separation of antigen pulsed cells and Fr 23 and 24 from the HPLC
separation of sham pulsed cells. An extra antigen derived peptide (MW 2069.1) is
shown in fraction 23 of the HPLC separation of the eluted antigen pulsed peptide
pool which is absent from the control fractions.
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1.2.4 Advances in biochemical techniques
The final section of the introduction will briefly review the biochemical
techniques upon which the analysis of MHC class II eluted peptides is dependent,
namely mass spectrometry and HPLC. The most recent advancements in these
biochemical techniques will be reviewed and the potential use of these 'new'
techniques in simplifying biochemical analysis of complex peptide mixtures
highlighted. These advancements include in mass spectrometric-based protein
labelling and the development of multidimensional liquid chromatography. Such
advancements have great suitability for antigen processing studies in which
thousands of peptides need to be efficiently separated prior to MS analysis.
1.2.4.1 Mass spectrometry
Mass spectrometry (MS) is a technique used to accurately measure the mass
to charge ratio (m/z) of ions. It is routinely used to identify unknown proteins either
by the mass of the protein itself or by the masses of its fragments, to determine the
structure of compounds and to quantify compounds in samples of interest (Hamdan
and Righetti, 2002; Aebersold and Mann, 2003; Sommerer et al., 2006). The
development of two 'soft' ionisation techniques in the 1980's known as electrospray
ionisation (ESI) and matrix-assisted laser desorption ionisation (MALDI) led to the
application of mass spectrometry to many biological problems including the
identification of proteins (Siuzdak 1994). This is because 'soft' ionisation
techniques allow large analytes, for example proteins, to become ions without
significant fragmentation, thereby making their molecular weight obtainable using
mass spectrometry. Soft ionisation techniques also give rise predominantly to a
singly positively charged parent ion (M+l) during mass spectrometric analysis,
making them ideal for many applications including the identification of large
macromolecules.
In MALDI-MS, a laser is used to ionise the sample, generating positively
charged gaseous ions. The sample is mixed with a substance called the 'matrix' that
absorbs the laser energy and transfers it to the sample, thereby preventing
fragmentation of the analyte. In ESI, the analyte is passed through a capillary held at
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high potential, leading to evaporation of the droplets and the production of charged
gaseous ions. Following ionisation of the analyte by one of these soft ionisation
techniques, the ions are separated in a mass analyser according to their mass / charge
ratio (m/z) and the then recorded by a detection system. This information is acquired
under the control of a data processing system that generates a mass spectrogram,
from which the mass of the ion is obtained. The detector records the signal as an
electron cascade, which is displayed on an oscilloscope, and then the data is shown
graphically as m/z (x axis) against the number of ion hits (y axis). Since charge (z) is
equal to +1, then m/z is equivalent to the mass of the ion. Commercially, both
MALDI and ESI ion sources are found in conjunction with different types of mass
analysers. These mass analysers include time of flight (TOF), ion trap (IT),
quadropole, and fourier transform ion cyclotron resonance (FT-ICR).
1.2.4.1.1 Matrix-Assisted Laser Desorption Ionisation - Time Of Flight
(MALDI-TOF) mass spectrometry
Figure 6 shows a diagram of a MALDI-TOF mass spectrometer and
illustrates how such an instrument works. In MALDI-TOF, the ions are accelerated
towards the detector along a flight vessel at a speed determined by the mass of the
ion, with lighter ions reaching the detector first. The mass of the ion is calculated
from the drift time and is shown in figure 1.7. Since almost all ions possess only a
single positive charge, time of flight is proportional to the square root of the mass of
the ion.
Time of flight mass spectrometry works on the principle that if ions are
accelerated with the same potential from a fixed point at a fixed initial time and are
allowed to drift, the ions will separate according to their mass to charge ratios.
Flowever, when accelerated, ions exhibit a broad spread of energy, causing them to
travel towards the detector at different speeds. Thus, ions of the same mass reach the
detector at slightly different points in time. The use of Delayed Extraction
technology overcomes this initial distribution of energies, with ions being formed in
a weak electrical field, and then a high voltage pulse applied after a predetermined
time decay to accelerate the ions. Delayed extraction is used to improve mass
accuracy.
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Once the ions have reached the end of the flight tube, they are detected in
either linear or reflector mode. In the latter, an electrostatic mirror is used to reflect
the ions during their course, causing them to travel a further distance prior to
detection. This longer drift time gives rise to greater mass accuracy during detection.
Development of the 'reflector' mode has enabled individual isotopic peaks of
peptides to be visualised during mass spectrometric analysis. Prior to this, only one
peak for a peptide could be identified during linear detection. The visualisation of
individual isotopic peaks during mass spectrometric analysis has paved the way for
the isotopic labelling of proteins that is currently used to identify and quantify
compounds in complex samples.
1.2.4.1.2 Tandem mass spectrometry
Soft ionisation techniques do not lead to the fragmentation of proteins or
peptides. As a consequence, only mass information is acquired during analysis using
soft ionisation techniques. In order to provide structural information, many mass
spectrometers available upon the market are now tandem mass spectrometers in
which peptides or proteins are fragmented to obtain sequence or structural
information (Fenselau et al., 1993; Lemmel and Stevanovic, 2003). These
instruments include triple quadrupole, quadrupole ion trap, quadrupole time of flight
instruments and MALDI-(TOF/TOF) instruments.
In tandem mass spectrometry, a first mass analyser is used for selection of the
desirable ion. The ion is then subjected to fragmentation by collision with an inert
gas inside a 'collision chamber'. This is called low-energy collision induced
dissociation (CID). A second mass analyser is then employed to separate out
fragment ions based upon their m/z values. From these fragments, a partial sequence
can be determined for peptides using known information of the expected
fragmentation patterns. This technique is extremely powerful and is commonly used
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Figure 1.6 Diagram of a MALDI-TOF mass spectrometer
Figure adapted from Voyager ™ Biospectrometry ™ Workstation User's Guide
(a) Shows how a MALDI-TOF mass spectrometer works
(i) The sample plate is placed into a loading chamber.
(ii) Upon loading, the sample plate is taken to a main source chamber where the
sample is ionised by a laser.
(iii) Positive ions are subsequently propelled along a flight tube to a detector
(iv) Detection can either be in linear mode or reflector mode. In the latter, the
path of the ions is deflected using an electrostatic mirror, increasing their
flight distance prior to detection.
(b) The sample is mixed with a component called the matrix that absorbs the laser
energy and transfers it to the analyte molecules, leading to ionisation without





t = drift time
s = drift distance
m = mass
KE = kinetic energy
n = number of charges on ion
Figure 1.7 Equation used to derive ion mass
(Taken from Voyager ™ Biospectrometry ™ Workstation Users's
Guide)
The time taken for the ions to reach the detector at the opposite end of
the flight tube (drift time) is proportional to the square root of the mass
of the ion and is calculated using the equation above. Approximate ion
mass is determined in this way.
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1.2.4.2 Mass accuracy and calibration
Unless a tandem mass spectrometer is employed, structural information is not
obtained for an unknown peptide / protein species. It is therefore paramount that
accurate masses are obtained during the acquisition of data. The mass of the ions is
measured in Daltons in mass spectrometry. Mass accuracy indicates the accuracy of
the mass information provided by a mass spectrometer. It is the difference which is
observed between the theoretical mass and the measured mass and is expressed in
parts per million (ppm). Equations explaining the derivation of mass accuracy are
shown in figure 1.8a. Mass accuracy is linked to the resolution capability of the mass
spectrometer in use and represents the ability to separate two adjacent masses. Thus,
the mass of an ion can only be measured as accurately as the instrumentation allows.
For optimum mass accuracy, the mass spectrometer is calibrated using
standards of known mass. The mass spectrometer should be calibrated at least once a
day but most commonly, calibrants are included during the analysis of each sample.
A calibration file is generated based upon the observed time of flight of masses of
known calibration standards. The file is generated using standard mixtures containing
components with masses throughout the range of interest. The calibration file is then
used to adjust the masses of unknown peptide / protein species in the sample of
interest, thus correcting for any mass inaccuracies resulting during the acquisition of
data. The calibration software compensates for changes in accelerating voltage
during acquisition that may lead to ions of the same mass / charge ratio reaching the
detector at slightly different times, thus compromising mass accuracy. The general
calibration equation employed by the mass spectrometer used is this project in shown
in fig 1.8b.
The calibration function allows the generation of two types of calibration:
external and internal calibration. An external calibration file is generated when the
standards are not mixed with the sample and are therefore analysed separately. In
contrast, an internal calibration file is generated when the standards are mixed with
the sample and thus analysed at the same time. Internal calibration provides better
mass accuracy compared to external calibration and is commonly used for the
calibration of unknown peptide masses in the identification of proteins in MS peptide
finger printing (Sommerer et al., 2006).
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Mass accuracy (Am) = mass real - mass measured
It is often expressed in parts per million (ppm):
ppm = 106 * Am accuracy / mass measured
i.e.: theoretical mass: 1000, measired mass: 999.9 error: 100 ppm
t=t0 + A Jmlz + (higher order terms)
Where:
t= time of flight
t„= Difference in time between the start time of the analysis and
the time of ion extraction in Delayed Extraction,
A = Effective Length (mm) x x 10»
\ Accelerating Voltage (Kv)
Where:
m,^ 1 dalton mass in SI units (1.66054x10'^ kg)
e = charge of electron in SI units (1.602177 x 10'19 coulomb)
Effective length = length of flight tube corrected for an ion
acceleration through the stages of the source and flight tube,
and for the impact of the guide wire.
nVz= mass-to-charge ratio
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Figure 1.8 Mass accuracy and calibration equations
(Taken from Voyager ™ Biospectrometry™ Workstation Users's Guide)
The above figure shows the derivation of the equations for mass accuracy and
calibration, (a) Mass accuracy is the difference between the theoretical mass and
the measured mass and it is expressed in parts per million (ppm). (b) To obtain
accurate ion masses, a calibration procedure using reference standards of known
mass is used. For each standard, values for to and A are calculated which are based
upon the configuration of the system such as flight tube length and accelerating
voltage. The calibration file created from the time of flight of known standards is
then applied to mass spectra containing ions of unknown mass. This calibration
software compensates for changes in accelerating voltage that is used to propel the
ions along the flight tube.
1.2.4.3 Use of stable isotopes in protein labelling
• 1S 18 IT
Stable isotopes (e.g. N, O and C) are being increasingly used in
proteomics for protein quantification and identification (Chen et al. 2000; Hamdan
and Righetti 2002; Aebersold and Mann 2003; Tao and Aebersold 2003). Stable
isotopes are introduced into proteins by either metabolic labelling with heavy salts /
aminoacids / carbohydrates; or enzymatically via the transfer of 180 from water to
peptides or by chemical reactions. This technique is based upon the fact that
chemically identical analytes of different stable-isotope composition can be
differentiated in a mass spectrometer based upon either a difference in mass (15N,
18 •• 13
O) or overall isotopic pattern ( C). The metabolic labelling of antigens with stable
isotopes overcomes the short comings of both discrete labels and radioactive
labelling as they are both safe to use and are incorporated into the framework of the
antigen, preventing the labelling process from interfering with processing and
presentation of the antigen.
To date, however, stable isotopes have been used in few studies analysing
naturally processed and presented peptides (Lemmel et al., 2004; Ringrose et al.,
2004; Meiring et al., 2005). The only example of the use of stable isotopes in the
identification of CD4+ T cell epitopes was provided by Meiring et al., (2005) who
identified a number of CD4+ T cell epitopes from the meningococcal outer
membrane protein porin A (Por A) by analysing MHC class II eluted peptides. In this
study, bacteria were cultured in minimal media containing either 14NH4C1 or
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15NH4C1, and then the outer membrane vesicles (OMV) containing Por A
subsequently isolated and used to pulse dendritic cells in a 1:1 ratio. The MHC class
II peptides were subsequently isolated, separated by HPLC and labelled peptides
identified as 'spectral couplets' during mass spectrometric analysis. These couplets
are generated by labelled peptides increasing in mass following the incorporation of
l5N.
1.2.4.3.1 Carbon-13 labelling technique
Whereas 100% labelling with l5N leads to a discrete change in mass, the
• •IT
overall isotopic pattern of peptides can be changed by labelling with 2.3% C (Zou
et al., 2004). Therefore, instead of distinguishing spectral couplets in complex
spectra, peptides labelled with carbon-13 should be distinguishable from all other
peptides in the spectra. This approach is based upon the fact that there are two stable
19 IT
isotopes of carbon, carbon-12 ( C) and carbon-13 ( C). Carbon-12 represents
• IT •
98.892% of all naturally occurring carbon atoms whilst C represents 1.08%, giving
rise to peptides with characteristic isotopic patterns.
For a given peptide, the first peak represents detection of ions of peptides
with zero carbon 13 atoms, the second represents the number of molecules with one
IT 1T
C atom, and the 3rd represents those with two C atoms and so forth. The relative
abundance of these peptide ions depends on the proportion of 13C and the number of
C atoms within the peptide, and can be calculated using the binomial distribution
(figure 1.9). The analysis suggests that 13C enriched peptides should be clearly
distinguishable from peptides containing the usual abundance of 13C by differences
in their isotope pattern, provided account is taken of their length and the likely range
of carbon atoms they contain. Thus, this labelling technique has potential to produce
labelled peptides that are easier to identify because they appear visually distinct to
unlabelled peptides. Although this approach has not been used in antigen processing
studies, experimental work with the test protein Schistomal glutathione transferase
(sGT) has shown this 13C labelling technique to be a highly sensitive and
reproducible method of identification of labelled peptides in complex mixtures.
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Figure 1.9 Predicted isotopic patterns for peptides of different mass at
four different carbon-13 abundances
Each peptide species in a mass spectrogram is made up of several isotopic
peaks, one mass unit apart, due to peptide ions containing 0, 1, 2 etc. atoms
of carbon-13. The expected relative abundance of peptide ions containing
0-4 carbon-13 atoms is calculated from the binomial distribution. The
number of carbon atoms and the abundance of carbon-13 influence the
pattern. Error bars indicate the degree of variation in the patterns seen with
peptides containing 1.96 standard deviations more or fewer carbon atoms
compared to the mean number of carbon atoms per dalton found in human
proteins. Vertical comparison demonstrates that carbon 13-enhanced
peptides have distinct isotope patterns at each of the representative masses
(Zou et al., 2004).
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1.2.4.3 High Performance Liquid Chromatography (HPLC)
HPLC is commonly employed to separate, purify, identify and quantify chemical
substances (Issaq et al., 2002). Prior to the development of HPLC in the mid-
seventies, most chemical separations were carried out using a variety of techniques
including open-column chromatography, paper chromatography, and thin layer
chromatography. However, these techniques were inadequate for the quantification
of compounds and resolution between similar compounds. The use of high pressure
or high performance liquid chromatography (HPLC) as it is commonly referred to
has resulted in a reduction in flow through time and the purification time of
compounds.
HPLC separation of complex peptide mixtures prior to mass spectrometric
analysis is the common method of biochemical analysis in both proteomic studies
and in the characterisation of MHC associated peptides (Lemmel and Stevanovic,
2003). In 1992, Hunt et al. first pioneered the use of liquid chromatography -
MS/MS for the analysis of complex peptide mixtures by studying MHC class I
associated peptides. Since this initial study, single dimensional chromatography has
routinely been used prior to either tandem mass spectrometry or MALDI mass
spectrometry in studies characterising both class I and class II peptides. It has,
however, become apparent that one dimensional chromatography does not provide
sufficient peak capacity to efficiently separate peptide mixtures as complex as those
eluted from MHC molecules, or total cell lysates in the case of proteomic studies.
With the advent of proteomics, various combinations of peptide separation
techniques have been explored in order to provide better separation of complex
peptide mixtures (Wang and Hanash, 2003). The most popular of these is strong
cation exchange followed by reverse phase chromatography. Whereas a 1D
chromatographic system equipped with a standard reverse phase column can only
efficiently resolve about one hundred peptides, a 2D separation system has the
potential to resolve thousands of peptides (Michrom Biosciences, application note
No. 111). As a direct result of the enormous improvement in the separation
capability of these systems, multi-dimensional liquid chromatography has been
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successfully employed in many proteomic studies, identifying thousands of proteins
in proteomes isolated from both cells and pathogens (Nilsson, 2002; Wilson et al.,
2004). Although 2D HPLC has not yet been used in antigen processing studies, it
has great potential to significantly improve the separation of peptides compared to
traditional ID separation techniques.
1.3 Purpose of project
The purpose of this project was to test whether the carbon-13 labelling
technique could be used to identify peptides of immunological interest within
complex mixtures. The ultimate aim of the work would be to use the carbon-13
labelling technique to identify naturally processed and presented MHC class II bound
peptides derived from whole bacteria.
With this in mind, development of the approach initially employed the use of
outer membrane proteins isolated from 3 different strains of E. coli. Using these
extracts, work was carried to identify immunologically relevant outer membrane
proteins and to produce carbon-13 labelled proteins. Following preliminary work, the
project switched to using the single antigen tetanus toxin C fragment (TTCF) to
simplify characterisation of carbon-13 labelled peptides following their identification
in complex peptide mixtures. It was hypothesised that following validation of the
technique using a single antigen, the more complex bacterial outer membranes could
be subsequently analysed using the same technique. Using this antigen, work was
carried out to identify fragments generated following the in-vitro digestion of TTCF
using lysosomal extracts isolated from lymphoblastoid human B cells. This was
carried out with the intention of subsequently going on to study naturally processed
and presented TTCF peptides bound to MHC class II molecules at the cell surface.
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2. Methods and materials
2.1 Cells and reagents
2.1.1 Bacterial strains and toxins
The bacterial strains used in this project were E. coli 018, K12 and 012.
These strains were chosen from a bank of freeze-dried bacterial strains kindly
provided by Professor Ian R Poxton's laboratory at Edinburgh University. An N-
terminal histidine tagged tetanus toxin C fragment fusion was kindly provided by
Professor Colin Watts at Dundee University. This fusion protein was encoded by
pET 16B and expressed in the cell line E. coli strain BL21 (DE3).
2.1.2 B cell lines and cell culture conditions
The B cell line used in this study was the Epstein Barr virus (EBV)
transformed human Pala lymphoblastoid B cell line that was very kindly provided by
Professor Colin Watts at Dundee University. B cell media was made up using 1L of
GIBCO RPMI 1640 medium supplemented with 5% fetal calf serum, 200 mM L-
glutamine, 10,000 units / ml penicillin, and 1 Omg / ml streptomycin solution. The B
cells were grown in 25ml of this medium and incubated at 37 °C with 5% C02. The
B cells were split 1 in 4 using fresh B cell media culture 3 times a week.
2.2 Methods - part 1
2.2.1 Carbon-13 labelling of bacterial outer membrane proteins
To produce carbon-13 labelled bacterial outer membrane proteins, the
appropriate E. coli strain was grown in M9 minimal medium supplemented with
carbon-13 glucose, as described previously (Zou et al., 2004). The bacteria were
initially grown in a starter culture of between 5-15 ml of Luria broth (LB) (lOg
tryptone, 5g yeast extract, lOg NaCl; per litre) and then diluted into either a larger
volume of LB broth or into M9 minimal medium (see table 2.1 for recipe) to give a
carry over of 3.3% of the initial starter culture. This amount of carry over of rich
broth into minimal medium is negligible. The amounts of carbon-13 glucose used for
49
enrichment were 2.3%, and 3.3%, given as a percentage of the total amount of
glucose in the growth medium. To obtain these percentages of carbon-13 in the
growth media, 70mg (for 2.3%) and lOOmg (for 3.3%) of carbon-13 labelled glucose
was added.
M9 minimal medium (1L)
♦ 800ml H20
♦200ml 5*M9
(0.24M Na2HP04, 0.11M KH2P04, 0.043 M NaCI)
♦1ml salt mix
(4mM ZnS04, 1mM MnS04, 0.7mM H3B03, 0.7mM CuS04)
•2ml 1M MgS04
♦ 2ml 50Mm CaCI2
♦ 400(jl 5mM FeCI3
♦ 800pl thiamine (0.5mg/ml)
♦ 9.4ml NH4CI2
♦15ml Glucose [20% (w/v)]
♦1ml carbenicillin (50mg/ml)
• 4.6ml 13C-glucose (15mg/ml)
Table 2.1 Recipe for M9 minimal medium
% glucose calculated as (w/v)
2.2.2 Extraction of E. coli outer membrane extracts
Outer membranes were extracted from E. coli using the 'Sarkosyl' method
(Filip et al., 1973). Bacteria were initially grown to late log phase (OD55o -0.8) in
either LB broth or M9 minimal medium spiked with carbon-13 glucose and
harvested by centrifugation at 10,000g for 15 minutes at 4°C. The cell pellets were
subsequently washed 3 times in 50ml of 0.05M sodium phosphate buffer (0.05M
NaH2PO4.2H20 and 0.05M Na2HP04; pH 7.4) containing 0.15M sodium chloride.
Following each wash, the cell pellet was recovered by centrifugation at 10,000g for
15 minutes, carried out at 4°C using a Sorvall RC5B centrifuge. After the 3 wash
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steps, the cells were resuspended in 9ml of pyrogen free water and disrupted by
sonication which was carried out on ice for 1 minute, using an amplitude of 5- 10pm
(MSE Soniprep 150). The sonication step was carried out a total of 6 times, with the
cells being left on ice for 30 seconds between each sonication step. To solubilise the
outer membrane, 7% Sarkosyl solution was subsequently added to the cells to give a
final concentration of 0.07%. The unbroken cells were then removed by
centrifugation at 10,000g for 15 minutes, carried out at 4 °C using an
Eppendorf 581 OR centrifuge. The outer membrane proteins were subsequently
recovered by centrifugation at 50,000g for 1 hour at 4°C, washed in 10 ml of pyrogen
free water, and once again recovered by centrifugation at 50,000g for 1 hour at 4°C
using a Sorvall OTD centrifuge. Following the wash step, the insoluble outer
membrane pellet was re-suspended in 1ml ofwater and stored at -20 ° C until use.
2.2.3 Confirmation of carbon-13 labelling of bacterial proteins in outer
membrane extracts
To confirm that the proteins were labelled and to determine the correct
amount of labelling, the outer membrane extracts were run out on a 10% SDS-PAGE
gel. Prior to SDS-PAGE analysis, the outer membrane proteins were boiled in 2%
SDS for 3 minutes. Protein bands were then excised from the gel, sliced into 1mm
cubes, and washed 3 times in water. They were then dried under vacuum in a speed
vac (Savant AES 1000 / AES 1010). The dried gel pieces were subsequently reduced
by incubating the gel pieces with lOmM DTT in 50-1OOpl of lOOmM NH4 (HC03)2 /
5% ACN for 45 minutes at 56°C. The gel pieces were then alkylated by incubating
the gel pieces with 50mM iodoacetamide in 50-1 OOpl lOOmM NH4 (HCC^ in the
dark for 2 hours. Following alkylation, the gel pieces were placed in a speed vac and
dried and then 20pg of modified porcine trypsin (Promega) added in a 50mM tri¬
phosphate buffer (pH 7.4) to digest the protein for 4 hours at 37°C. After digestion,
the peptides were extracted from the gel pieces by initial incubation with 100pl of
50% ACN / 50% NH4(HC03)2 for 10 minutes (repeated once) followed by
incubation for a further 10 minutes with 100pi 5% formic acid / 50% ACN (repeated
once). All of these extracts were pooled together and dried under vacuum in a speed
vac to a volume of lOpl.
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2.2.4 MALDI-MS sample preparation & data acquisition
To prepare the extracts for matrix assisted laser desorption ionisation - time
of flight mass spectrometry (MALDI-TOF MS), 30jliI of 0.1% trifluoroacetic acid
(TFA) was added and the extracts briefly vortexed, and then sonicated for 15
minutes. The samples were concentrated using a Zip Tip™ (Millipore) and then
eluted using saturated matrix solution (a-cyano-4-hydroxycinnamic / 70% ACN /
0.1% TFA). The eluted peptides were spotted directly onto a 400 well MALDI plate.
The matrix, a-cyano-4-hydroxycinnamic (Sigma), co-crystalised with the peptide
extracts by the dried droplet technique. The dried sample was then analysed in a
Voyager DE Pro mass spectrometer in reflector mode with an extraction delay of
180ns, accelerating voltage of 20,000V, grid of 76%, and by examining the mass
range 600-4000 Daltons. Per spectrum, 400-800 laser shots were collected, with all
spectra being subsequently processed to remove electronic noise and to smooth the
baseline. Peptides were calibrated using the two autolysis products of trypsin (842.51
Da and 2211.1 Da).
2.2.5 Determination of the amount of protein in outer membrane extracts
The amount of protein (mg/ml) in the outer membrane extracts was
determined using the Lowry method (Lowry el al., 1951). Between 10-50pl of the
outer membrane extracts were added to 350pl of distilled water and then mixed with
1.2ml of 12.5% NaCC>3 and 0.2ml of 0.1% CUSO4.5H2O for 60 minutes at room
temperature. During this time, a 1 in 3 dilution of Folin & Ciocalteu's phenol reagent
was prepared and 0.2ml of the reagent added to each sample tube at the end of the
incubation period. The samples were then incubated at room temperature for a
further 25 minutes and the OD750 measured in a spectrometer. Two controls were
used in the assay. In these controls, the sample was replaced with either 25pi or 50pl
of a 2mg/ml solution of bovine serum albumin (BSA). The amount of protein,
expressed as mg / ml, was then determined using the following calculation:
O.D .750 sample* volume of standard * 2 O.D.750 standard * volume of test assayed
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2.2.6 Staining of outer membrane extracts for proteins and LPS
Following SDS-PAGE analysis, outer membrane proteins were stained using
the Coomassie staining method (Hancock and Poxton, 1988). The gels were initially
placed overnight into solution 1 (lg Coomassie brilliant blue R-250, 500ml
propanol-2-ol, 200ml acetic acid, 1300ml distilled water) and then into solution 2
(lOOmg Coomassie brilliant blue R-250, 200ml propanol-2-ol, 200ml acetic acid,
1600ml distilled water), solution 3 (48mg Coomassie brilliant blue R-250, 200ml
acetic acid, 1800ml distilled water) and solution 4 (800ml methanol, 200ml acetic
acid, 1000ml distilled water) for 1 hour intervals. Between each stain, the SDS-
PAGE gel was washed 3 times in water for 10 minute intervals. The gel was finally
placed into solution 5 (200ml acetic acid, 1800ml distilled water) and left in this
solution until further use.
SDS-PAGE gels were stained for LPS using the silver staining method (Tsai
and Frasch, 1982). The gel was placed overnight into LPS fixative (25% propan-2-ol,
7% acetic acid) and then placed into oxidising solution (0.7% periodic acid / 25%
propan-2-ol) for 15 minutes. The gel was subsequently washed 4 times with distilled
water for 1 hour intervals. Ammoniacal silver nitrate (0.36% NaOH, 19.4% silver
nitrate) was then applied for 15 minutes and the gel was once again washed with
distilled water for a 10 minute period. The developer was subsequently added
(0.005% citric acid in 0.019% formaldehyde solution) until the gel was sufficiently
stained and then washed away with distilled water.
2.2.7 Protein identification by mass spectrometric fingerprinting
Proteins were excised from the gel and reduced, alkylated, and digested as
described in section 2.2.3. Peptide-mass fingerprinting subsequently identified them.
Spectra were de-isotoped prior to being submitted to the Matrix Science database so
that only a single peptide mass was entered into the database for each peptide
species. The masses were internally calibrated using the two trypsin autolysis peaks
(842.51 and 2211.1) present in the spectra. The calibrated masses of tryptic peptides
were then submitted into the Matrix Science database for protein identification. The
search criteria restricted the search to the E. coli genus and allowed a mass deviation
of 50 ppm, oxidation ofmethionine residues and up to 2 missed cleavage sites by the
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enzyme. The probability that the matching protein candidates did not match by
chance to the unknown protein was calculated by the database using the MOWSE
probability algorithm (Pappin et al., 1993), with scores over 57 being termed a
significant hit.
2.2.8 Identification of serum antibodies binding to outer membrane proteins
and LPS
E. coli outer membrane extracts were transferred overnight onto
nitrocellulose using a BioRad Western blotting tank (5V; 40mA). The following
morning, the nitrocellulose was washed in TBS (0.02 M Tris-HCl, 0.5M NaCl;
pH 7.5) for 10 minutes and then incubated with 'blocking' solution (3% fish gelatine
dissolved in TBS) for 1 hour. The nitrocellulose was subsequently cut into strips and
incubated for 3 hours with one of the serum samples diluted 1 in 30 with 'antibody'
solution (1% fish gelatine dissolved in TBS). A control was included in which no
serum was added to the nitrocellulose strips. The membranes were subsequently
washed with TTBS (0.02M Tris-HCl, 0.5M NaCl, 0.025% Tween 20; pH 7.5) for 10
minutes. The bound antibodies were then detected by incubation of the immunoblots
with an anti-human horse radish peroxidase-enzyme IgG conjugate for 1 hour
(Sigma) and developed using horse radish peroxidase development solution (solution
A [60mg 4-chloro-l-naphthol, 20ml methanol], solution B [60pl H202, 100ml
TBS]; mix together prior to use).
2.3 Methods - part 2
2.3.1 Development of a nano-flow liquid chromatography (LC) system
A nano-flow LC system was set up in the laboratory for the purpose of
separating picomole amounts of peptides in complex mixtures. See chapter 4 for a
detailed explanation of the system set up.
2.3.2 Sensitivity of the nano-flow LC system
The sensitivity of the nano-flow LC system was tested using calibration
mixture 2 (Applied Biosystems) which contained the following synthetic peptides at
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different concentrations in the final mixture: Angiotensin I (2.0 pmole/pl), ACTH
clip 1-17 (2.0 pmole/pl), ACTH clip 18-39 (1.5 pmole/pl), ACTH clip 7-38 (3.0
pmole/pl), and bovine insulin (3.5pmole/ pi). Different amounts of the synthetic
peptide mixture, was injected into the nano-flow LC system to test system
sensitivity.
2.3.3 Separation capacity of the nano-flow LC system
The separation capacity of the nano-flow LC system was tested using a
tryptic digest of E. coli outer membrane proteins. Ten micrograms of E. coli outer
membrane extracts was resuspended in lOOpl of pyrogen free water and boiled in 2%
SDS for 5 minutes, reduced at 56°C with lOmM DDT in lOOmM NH^HCC^ / 5%
ACN for 45 minutes, and then alkylated for 2 hours in the dark with 50mM
iodoacetamide dissolved in lOOmM NH4(HC03)2. Twenty micrograms of trypsin
was then added in a tris-phosphate buffer (pH 7.4) and digestion permitted for 4 hour
at 37°C. In order to test sensitivity of mass spectrometric detection, the digestion
4 T £ . Q
mixture was then diluted 1 in 10 , 1 in 10 and 1 in 10 using phosphate buffered
saline (PBS). The original digest and diluted digestion mixtures were then passed
through strong cation exchange centrifugal devices (Amicon, Millipore) to remove
any detergent and the bound peptides subsequently eluted by the addition of 100pi of
1.4N NH4OH followed by lOOpl of 1% TFA. The digestion products were then
placed in a speed vac until a volume of lOpl and subsequently diluted 1 in 10 with
0.1% TFA in pure water (ROMIL). To visualise the complexity of the unseparated
solution, lOpl of digestion products were concentrated using a Zip Tip™ and
analysed by MALDI-TOF MS.
2.3.3.1 One-dimensional and 2 dimensional nano-flow LC separation
Forty five microlitres of a tryptic digest of the outer membrane extracts
(~4.5pg outer membrane proteins) were placed into a speed vac to a volume of lOpl
and then mixed with reverse phase (RP) buffer A (10% ACN / 0.08% TFA). The
extracts were then separated using a C18 15cm x 75pm reverse phase column (LC
packings). The method is shown in figure 2.1. During 2D separation, 45pl of a
tryptic digest of the outer membrane extracts was dried under vacuum to a volume of
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lOfj.1 in a speed vac and then diluted 1 in 5 with ion exchange (IEX) chromatography
buffer A (10% ACN, 0.08% TFA). The extracts were initially separated using a
Magic Bullet strong cation exchange column (Michrom biosciences, USA) and the
peptides eluted from the column using 'salt plugs' of NH4OH of increasing
concentration: 50mM, lOOmM, 250mM, 500mM, 1M. The peptides eluted by these
salt plugs were caught by a CI8 capillary trap (LC packings) and subsequently
separated by a CI8 capillary reverse phase column. For both ID RP and 2D IEX-RP
separation, eluted peptides were mixed 1:1 with saturated matrix solution and
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Figure 2.1 Sequence of events and gradient profile used during a reverse phase
(RP) chromatographic separation
a) Table showing the computerised events of a RP liquid chromatography run. The
different components of the liquid chromatography system were started and
coordinated by a computer program package called DAQ factory. The timing of
each event is shown in the table.
b) Graph showing the ACN gradient profde used during RP separation. An
increasing gradient of ACN was used to elute peptides from the RP column. The
gradient reaches 60% buffer B over a period of 65 minutes. The gradient was then
rapidly increased to 100% buffer B for 10 minutes and subsequently equilibrated
with 100% buffer A for a further 10 minutes.
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2.4 Methods - part 3
2.4.1 Production of carbon-13 labelled tetanus toxin C fragment (TTCF)
A histidine-tagged domain of tetanus toxin was expressed and purified as
previously described (Hewitt et ai, 1997). Recombinant-TTCF includes residues
872-1,315 of the toxin preceded by MGHGHHHHHHHHHHSSGHIEGRHI. E. coli
expressing recombinant-TTCF was grown at 37 °C in either 1L of LB broth or M9
minimal medium to an OD750 value of between 0.5-0.6 and the expression of TTCF
induced using 0.2 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) for a period
of 3 hours. Carbon-13 glucose was added to the minimal medium at the time of IPTG
induction so that it was incorporated into the protein framework during expression.
The amount of carbon-13 glucose used for enrichment was 2.3%, given as a
percentage of the total amount of glucose in the growth medium. To obtain this
percentage, 70mg of carbon-13 glucose was dissolved in 5 ml of filter sterilised
water and then added to the growth media. Following induction, bacteria were
harvested by centrifugation for 15 minutes at 10,000g, and the pellet re-suspended in
5ml of 'lysis buffer' (25 mM Imidazole / 500mM NaCl / lOOmM Tris-HCl). The
cells were subsequently lysed by sonication six times at 1 minute intervals to give the
total cell protein (TCP) and lOpl removed for SDS-PAGE analysis using a 12 %
acrylamide gel.
2.4.2 Purification of carbon-13 labelled tetanus toxin C fragment (TTCF)
Recombinant TTCF was purified using a His-tag column packed with Ni
chelated to iodoacetamide (IAA) 4b Sepharose beads (bed depth 3ml; total column
length 12 ml). Prior to the addition of the TCP to the His-Tag column, the beads
were washed 3 times using 10ml ofwater and loaded with MCI2 (0.1M NiCh, lOmM
Na acetate). The column was once again washed 3 times with 10ml of water
followed by a further 3 washes with 'conditioning buffer' (same as sonicating
buffer). The TCP was then added to the His-tag column, and the protein allowed to
bind for 5 minutes before the post load was collected. The column was then washed
3 times with 3ml conditioning buffer and the protein subsequently eluted using 3ml
of 'elution buffer' (500mM Imidazole / 500mM NaCl /lOOmM Tris-HCl). The
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elution procedure was repeated twice and all eluates combined. The purified r-TTCF
protein was then dialysed extensively into phosphate buffered saline (PBS) for 48
hours and stored at 4°C until use.
2.4.2 Isolation of lysosomes from B cells
Lysosomes were isolated from EBV-transformed lymphoblastoid human Pala
B cells as previously described (Davidson et al., 1990; Manoury et al., 1998). In this
technique, a combination of cellular lysis, Percoll based centrifugation, and
displacement fractionation is employed. Fractions containing lysosomes were
identified by the use of a fluorescent enzyme assay and then concentrated by
centrifugation for later use.
2.4.2.1 B cell lysis and fractionation of sub-cellular components
z o
B cells were grown to a density of 10 -10 cells, washed once in 10ml of cell
culture media and then twice in 10ml of homogenisation buffer (lOmM
triethanolamine, lOmM acetic acid, ImM Na2 EDTA, 0.25M 60% sucrose [w/v]).
After each wash, the cells were recovered by centrifugation at l,500g for 15 minutes.
After the final wash, the cells were re-suspended at 3 x 107 cells / ml in
homogenisation buffer, to give a total volume of 2-3ml. The cells were then passaged
on ice 8-10 times through a ball bearing homogeniser (EMBL, Heidelberg,
Germany), with a clearance of 6pm. The broken B cells were resuspended in 2-3ml
of homogenisation buffer and centrifuged at 2000rpm for 10 minutes at 4°C to obtain
the post nuclear supernatant (PNS). The PNS was slowly pipetted onto 23ml of a
27% Percoll solution (lOmM triethanolamine, lOmM HAc, ImM Na2 EDTA, 0.25M
60% sucrose, 27% Percoll). To fractionate the sub-cellular components, this solution
was centrifuged at 56,800g for 1 hour at 4°C and the centrifuge brake switched off to
prevent disruption of the sub-cellular gradient during de-acceleration. The gradient
was then fractionated using displacement apparatus set up to collect 25 fractions
from the bottom of the Percoll gradient upwards. During fractionation, a thin metal
tube attached to a pump was gently inserted to the bottom of the centrifugation tube
and the pump set to collect fractions at a speed of 1ml / minute. These 1ml fractions
were collected into tubes containing lOOpl of 0.5 M citrate buffer (pH 5.5).
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2.4.2.2 Determination of lysosomal fractions following sub-cellular separation
Fractions containing lysosomes were determined by the use of a fluorometric
enzyme assay to detect the activity of p-hexoseaminidase. This enzyme assay was
carried out in a 96-well ELISA plate. To all assay wells, 90pl of homogenisation
buffer and 100pi of the enzyme substrate 4-methylumbelliferyl n-acetyl p-D-
glucosamide (15.18mg dissolved in 0.1M citric acid (pH 4.5), 10% Triton X-100;
covered in foil) were added. Prior to the assay, the light sensitive substrate was
placed into a 37°C water bath for 15 minutes to dissolve the substrate. To each of the
25 test wells, lOpl of 1 out of the 25 fractions was then added. To a further 10
control wells, lOpl of homogenisation buffer was added in replacement of the
sample. The plate was then wrapped in foil and incubated at 37°C for 15 minutes.
Following incubation, the reaction was stopped by the addition of 0.1M glycine and
the ELISA plate read in a fluorescent plate reader (Cytofluor 4000® Series
Fluorescence Multi-well Plate Reader, Applied Biosystems), with emission and
excitation wavelengths set at 460nm and 350nm respectively.
2.4.2.3 Pooling of lysosomal fractions and concentration
Fractions containing lysosomes, as determined by the P-hexoseaminidase
enzyme assay, were pooled together and concentrated by centrifugation at 110,000g
for 1 hour using a Sorvall OTD centrifuge. The lysosomes form a cloudy white film
upon a Percoll pellet that can be recovered by careful pipetting. The recovered
cloudy white film is washed in 50mM citrate buffer (pH 5.5) and the lysosomes
harvested by centrifugation at 89,000g for lh using a Sorvall OTD centrifuge. The
lysosomes were then resuspended in 100pi of 50mM citrate buffer (pH 5.5) and
stored at -70 degrees until use.
2.5 Methods - part 4
2.5.1 Identification of labelled TTCF digestion products (<3KDa) following
lysosomal digestion
TTCF was digested using lysosomal extracts isolated from lymphoblastoid
Pala B cells, as previously described (Manoury et al., 1998). The small digestion
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products (<3KDa) were separated using 2D nano-flow LC and characterised using
MALDI-TOF MS.
2.5.1.1 Digestion conditions
To disrupt the lysosomal membrane and thus release lysosomal enzymes,
lysosomes were mixed with 0.02% CHAPS and left for 5 minutes on ice. The
lysosomes (+ 0.02% CHAPS) were then mixed with TTCF in a ratio of 1 to 5 and
incubated at 37°C for a period of several hours to allow digestion. All digestions
were carried out in the presence of 50mM citrate buffer to keep a pH optimum of
either 5.5 or 4.5 during digestion. Ten millimolar DTT was also included in the
digestion mixture to reduce the protein. At the end of the digestion period, the
reaction was stopped by the addition of 1M NH4OH. To analyse large digestion
species (>3KDa), a proportion of the digestion mixture was ran on a 10 well Novex®
16% Tricine Gel (Invitrogen) based on the tricine system developed by Schaegger
and vonJagow, 1987.
2.5.1.2 Two-dimensional IEX-RP nano-flow LC separation of digestion products
The digestion mixture was initially passed through a 3 KDa centrifugal filter
unit (Amicon®, Millipore). The 3KDa centrifugal filter unit was subsequently
washed with 5% ACN / 0.1 TFA % followed by 90% ETOH. The digestion products
were then placed in a speed vac and dried under vacuum to a volume of 1 Opl before
being re-suspended in 50pl of TEX buffer A' (H2O + 0.5% v/v HAc) ready for IEX
chromatography. The sample was injected onto a Magic Bullet strong cation
exchange column (Michrom, USA) and eluted using a continuous gradient of buffer
B (H2O + 0.5% v/v HAc + 35% ACN + 500mM KC1). The sequence of events
during an IEX run and the gradient profile used for separation are shown in figure
2.2. Forty fractions, each collecting 1-minute worth of flow, were collected manually
and subsequently pooled together according to their complexity as determined by UY
detection. This resulted in a total of 5 IEX fractions that were further separated using
RP chromatography. The acid washes were then added to the appropriate fraction.
The 5 IEX fractions were prepared for RP separation by drying them in a speed vac
to a volume of lOpl and diluting them 1 in 5 using RP buffer A (3% ACN, 0.8%
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TFA). The peptides were then injected onto a CI8 capillary trap and subsequently
separated using a CI8 reverse phase capillary column. Eluted peptides were mixed

























Figure 2.2 Sequence of events and gradient profile used during an ion exchange
(IEX) chromatographic separation
a) Table showing the computerised events during a IEX liquid chromatography
separation. The different components of the liquid chromatography system were
started and coordinated by a computer program package called DAQ factory. The
timing of each event is shown in the table.
b) Graph showing the KC1 gradient profile used during ion exchange chromatography.
An increasing gradient of KC1 was used to elute peptides from the strong ion
exchange column. The gradient reaches 60% buffer B over a period of 30 minutes.
The gradient was then rapidly increased to 100% buffer B over the next 5 minutes and





2.5.1.3 MALDI-TOF MS analysis
The set up of the mass spectrometer workstation used in this project is shown
in figure 2.3. See section 2.2.4 for sample preparation and data collection. Spectra
were calibrated using standard calibration mixture 2, either internally or by the use of
a close external calibration. Carbon-13 labelled peptides were identified in spectra by
visual analysis or by the use of the in house computer program called TSpec. Initial
analysis employed the Data Explorer software package (Perspective). Estimation of
the carbon-13 content was made by visual inspection of the isotopic pattern of
individual peptides within Data Explorer or by peak analysis with TSpec. The TSpec
program was used in conjunction with visual analysis and grouped together peaks
likely to constitute isotopes of individual peptides by recognising their compatible
mass to charge ratios and relative abundance. The TSpec program also estimated the
'labelledness' of the isotopic patterns for each peptide by calculating two parameters
(Zou et al. 2004). The first parameter, paramC13%, is an estimate of the carbon-13
content of a peptide calculated from the relative heights of its isotopic peaks. The
second, paramL is an estimation of the number of carbons per Dalton molecular
weight of a peptide calculated from the relative heights of the first two or three
isotopic peaks. Using these two parameters, the TSpec program awards a value of
'labelledness' to all of the peptides present in the mass spectra.
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Figure 2.3 Photo of the different components of the DE-PRO mass
spectrometer workstation
The mass spectrometer DE-PRO workstation consists of four components: (i) a
mass spectrometer (ii) a monitor (iii) a computer and (iv) a oscilloscope.
The sample plate is placed into a loading chamber. Upon loading, the sample plate
is taken to a main source chamber where the sample is ionised by a laser. The ions
are accelerated towards the detector along a flight vessel at a speed determined by
the mass of the ion, with lighter ions reaching the detector first. The detector
records the signal as an electron cascade displayed on an oscilloscope and shows
the data as mass / charge (m/z) against number of ion hits (y axis). Since charge
(z) is equal to +1 then m/z is equivalent to the mass of the ion.
Legend
A: Mass spectrometer B: monitor C: computer D: oscilloscope E: Sample loading
chamber F: Main source chamber G: camera H: laser I: Flight tube J: Detector
2.6 Methods - part 5
2.6.1 Identification of pre-digested TTCF tryptic peptides in complex mixtures
2.6.1.1 Characterisation of TTCF peptides
Labelled TTCF peptides were characterised following trypsin digestion by
mass matching to the TTCF sequence. The sensitivity and specificity of labelling
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were calculated as followed. The sensitivity was calculated by determining the
proportion of TTCF derived peptides that had a labelled isotopic appearance. The
specificity was determined by calculating how many peptides not matching to the
TTCF sequence displayed an unlabelled isotopic appearance.
2.6.1.2 Identification of pre-characterised labelled TTCF peptides in complex
peptide mixtures
The characterised and labelled TTCF tryptic peptides were mixed with
unlabelled peptides in two mixtures of differing complexity. In both mixtures, the
TTCF peptides were at a relative low abundance. The number of labelled TTCF
peptides detectable in both of these complex mixtures was determined before and
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after ID nano-flow liquid chromatography. For the first mixture, lOpg of three
unlabelled proteins were digested using trypsin: bovine serum albumin, bovine
haemoglobin, and chicken egg lysozyme. Fifty picomoles of this unlabelled digest
were mixed with ten pmoles of a tryptic digest of labelled TTCF. This mixture of
labelled and unlabelled tryptic peptides was Zip tipped and subsequently analysed
using MALDI-TOF MS.
To generate a more complex mixture, ~10pg lysosomes (+5mM DTT /
50mM citrate buffer/ 0.02% CHAPS) were incubated at 37°C for 4 hours to allow
autolysis. In order to test sensitivity of mass spectrometric detection, the digestion
mixture was diluted 1 in 103, 1 in 106and 1 in 109 using phosphate buffered saline
(PBS) and lOpl mixed with 10 pmoles of a tryptic digest of TTCF. The autolysis
products and labelled TTCF peptides were then passed through a 3 KDa cut off
membrane. The peptides were washed through the membrane using 50pi of 5% ACN
/ 0.1% TFA followed by 50pl 90% EtOH, dried to a volume of lOpl in a speed vac
(Savant AES 1000/ AES 1010) and then diluted 1 in 5 with RP buffer A.
2.6.1.3 Nano-flow LC separation of complex mixtures
Both the complex mixtures were separated using ID RP nano-flow LC
chromatography. Labelled peptides were subsequently identified by visual inspection
of the spectra for the pre-characterised tryptic fragments. A control was included in
which 10 pmoles of TTCF tryptic peptides alone was separated using ID RP nano-
flow LC. To test whether familiarity of the tryptic TTCF peptides influenced
identification, a person unfamiliar with the characterised tryptic TTCF fragments was
also asked to identify labelled peptides in the spectra.
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Chapter 3 Identification and carbon-13 labelling of E. coli outer
membrane proteins
3.1 Introduction
The bacterial antigens chosen for use in this study were outer membrane
proteins isolated from E. coli. The study chose to focus initially upon outer
membrane proteins because the outer membrane represents the barrier between
bacteria and their environment. Outer membrane proteins are therefore accessible for
antibody binding and are thus favourable targets for immune attack in the clearance
of extracellular bacterial pathogens. In addition to their surface exposure, outer
membrane proteins are prevalent amongst many different E. coli isolates (Overbeeke
and Lugtenberg, 1980), and have been shown to elicit protective immune responses
(Russo, McFadden et al., 2003). Therefore, the identification of conserved T cell
epitopes within outer membrane proteins may prove beneficial in the development of
subunit vaccines.
3.2 Objectives
• To show that the outer membrane proteins contain B cell epitopes by examining
whether healthy individuals have serum antibodies.
• To identify outer membrane proteins bound by serum antibodies using the mass
spectrometry-based technique called peptide mass fingerprinting.
• To generate and purify carbon-13 labelled bacterial outer membrane proteins and
to determine the isotope signature of carbon-13 labelled peptides derived from these
proteins.
3.3 Results
3.3.1 Outer membrane protein and LPS profiles of different E. coli strains
Outer membrane extracts were isolated from three strains of E. coli using the
well established 'Sarkosyf technique as described in the methods section. In this
procedure, the inner membrane and other proteins and lipids are solubilised by the
67
detergent Sarkosyl and the outer membrane is subsequently recovered as an insoluble
pellet by centrifugation. To examine the protein profile of the E. coli K12 outer
membrane, the outer membrane extracts were separated by Sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie blue.
Figure 3.1a shows that there are a number of dominantly expressed outer membrane
proteins in the outer membrane of E. coli K12. Three of these are in the higher
molecular weight range of between —33 and 37 KDa (bands 1, 2, 3) and two are
below 20 KDa in molecular weight (bands 4 and 5). These dominantly expressed
outer membrane proteins were also present in the outer membrane extracts of the
other two strains of E. coli. (3.1b). Analysis of the outer membrane extracts by
PAGE also revealed the presence of a number of less abundantly expressed proteins
which differed considerably between the three strains ofE. coli.
Outer membrane extracts from two of the E. coli strains, K12 (rough LPS)
and 018 (smooth LPS) were silver stained in order to detect the presence and
phenotype of LPS within the outer membrane extracts (3.1 c & d). LPS is the only
lipid in the outer leaflet of the outer membrane and consists of three regions: Lipid
A, the core structure, and the O antigen. Examination of the outer membrane extracts
isolated from E. coli K12 revealed a dense staining at the gel front, corresponding to
Lipid A plus core. This is the only part of the LPS molecule found in rough strains of
E. coli such as K12. In contrast, when examining the extracts isolated from E. coli
018, there was additional staining giving rise to a high molecular weight laddered
appearance that was absent from the rough strain. This staining corresponds to the O
antigen plus core plus Lipid A which is only found in smooth strains of E. coli, with




























Figure 3.1 SDS-PAGE analysis of the outer membrane protein and LPS
profiles ofE. coli
Outer membrane extracts were separated using a 10% SDS-PAGE gel. (a)
Coomassie blue staining of the outer membrane extracts ofE. coli K12 (b) The outer
membrane protein profile ofE. coli K12 is compared to E. coli 012 and 018. (c) &
(d) The outer membrane extracts from E. coli K12 and E. coli 018 have been silver
stained to detect the presence of LPS. Arrows 1-5 denotes major outer membrane
proteins. Protein bands 4 & 5 are not clear in gel (b).
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3.3.2 Detection of outer membrane protein and LPS specific antibodies in
healthy individuals
Unstained SDS-polyacrylamide gels of outer membrane extracts from E. coli
K12 and 018 were transferred onto nitrocellulose and incubated with serum
collected from healthy individuals. The immunoblots of E. coli K12 show that all 13
individuals had serum antibodies that bound to one or more of the major outer
membrane proteins (figure 3.2). However, the levels and pattern of binding differed
considerably between the individuals. In most individuals, the serum antibodies
bound most strongly to protein band 3 with a molecular weight of approximately -33
KDa. In comparison, weaker reactions were observed with the other outer membrane
proteins. Immunoblots of the E. coli 018 extracts using serum from 10 healthy
individuals (figure 3.3) showed similar results to E. coli K12. However, strong
reactions were also observed with protein band 4 (~17KDa), and in some individuals
with protein protein band 1 (~37KDa). It is unclear whether band 4 is a low
molecular weight protein or whether it is the rough form of LPS (lipid A plus core)
that is located at the gel front. In addition, there was also staining corresponding to
the binding of serum antibodies to the LPS O antigen. This gave rise to the
characteristic ladder pattern superimposed upon the outer membrane proteins in the
higher molecular weight range.
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Figure 3.2 Immunoblots showing the presence of serum antibodies that bind to E.
coli K12 outer membrane proteins from healthy individuals
Serum samples from 13 healthy individuals were immunoblotted against E. coli K12
outer membrane extracts. Numbers next to bands indicate outer membrane proteins
bound by serum antibodies.
X: No serum control
M: protein marker
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Figure 3.3 Immunoblots showing the presence of serum antibodies binding to
E. coli 018 outer membrane proteins from healthy individuals
Serum samples from 10 healthy individuals were immunoblotted against E. coli
018 outer membrane extracts. Numbers next to bands indicate outer membrane
proteins bound by serum antibodies.
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3.3.3 Identification of outer membrane proteins
The identities of the three outer membrane proteins within the molecular
weight range 30-40 KDa were investigated using the mass spectrometric based
technique known as 'peptide fingerprinting' (table 3.1). In this technique, the protein
band of interest is excised from the gel and digested with the enzyme trypsin. This
generates a characteristic set of peptide fragments that are unique to the protein and
are thus termed a 'peptide fingerprint' of the protein. The masses of these peptides
are accurately determined by MALDI mass spectrometry and searched against the
Matrix Science database. The database contains theoretical trypsin digests of all of
the proteins included within the search criteria. The search software compares the
theoretical masses of expected fragments of proteins to the experimental masses.
Significant protein matches are determined using the MOWSE algorithm (Pappin et
al., 1993) and the results returned in the form of a concise summary report. The
MOWSE score is a measure of the probability that the experimental masses could be
matched to the candidate protein by chance and takes into consideration both the
number of peptide matches and the percentage coverage of the candidate protein.
MOWSE scores over 57 were considered as significant hits (p<0.05).
Using the search criteria stated in the methods section, protein bands 1, 2, and
3 were identified as OMP F, OMP C and OMP A respectively (table 3.1). The
database search results for OMP F are shown in figure 3.4 to highlight the method
used for identification for all three proteins. In all three cases, the identified proteins
were the only proteins in the database likely to account for the major tryptic peptides
identified. In addition, sequence coverage of over 50% was observed for all three
proteins. The credence that can be placed in these identifications is very high because
of the method by which the outer membrane proteins were purified, the high
sequence coverage (figure 3.5), the high MOWSE score and by the fact that the
matches were of the correct molecular weight.
For each of the three proteins, intense signals in the peptide mass fingerprint
matched to expected tryptic fragments of the respective OMP. Peptides likely to
derive from OMP C were found in extracts of bands 1 and 3 as well as band 2,
presumably as a consequence of contamination during the excision procedure.
Unfortunately, band 4 was not successfully identified in this study. Similar studies
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have identified a major outer membrane protein of a corresponding molecular weight
as peptidoglycan associated lipoprotein (~18KDa). Alternatively, it may be that this
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Figure 3.4 Identification of outer membrane protein F
(a) Shown above is the procedure carried out during mass spectrometric
identification of proteins. The protein band is excised from an SDS-PAGE gel and
digested by trypsin. This generates a characteristic set of peptide fragments that are
unique to the protein and are thus termed a 'peptide fingerprint' of the protein. The
masses of these peptides are shown in (b) and are accurately determined by MALDI
mass spectrometry. The calibrated masses are submitted into the Matrix Science
database, which carries out theoretical trypsin digests of all of the proteins included
within the search criteria, (c) Significant protein matches are determined using the
MOWSE algorithm and the results returned in the form of a concise summary
report. The MOWSE score is a measure of the probability that the experimental
masses could be matched to the candidate protein by chance and takes into
consideration both the number of peptide matches and the percentage coverage of















Band 1 OMP F 50 14 113 50
Band 2 OMPC 53 18 181 66
Band 3 OMP A 39 11 107 55
Table 3.1 Identities of the major outer membrane proteins using peptide mass
fingerprinting
The identity of the three major outer membrane proteins within the molecular
weight range 30-40 KDa are shown in the table above.
See appendix 2 for more information on the database search results
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OMPC
1 MKVKVLSLLV PALLVAGAAN AAEVYNKDGN KLDLYGKVDG LHYFSDDKSV
51 DGDQTYMRLG FKGETQVTDQ LTGYGQWEYQ IQGNSAENEN NSWTRVAFAG
101 LKFQDVGSFD YGRNYGWYD VTSWTDVLPE FGGDTYGSDN FMQQRGNGFA
151 TYRNTDFFGL VDGLNFAVQY QGKNGSVSEG MTNNGREALR QNGDGVGGSI
201 TYDYEGFGIG AAVSSSKRTD DQNSPLYIGN GDRAETYTGG LKYDANNIYL
251 AAQYTQTYNA TRVGSLGWAN KAQNFEAVAQ YQFDFGLRPS LAYLQSKGKN
301 LGVINGRNYD DEDILKYVDV GATYYFNKNM STYVDYKINL LDDNQFTRDA
351 GINTDNIVAL GLFYQF<
Sequence matches are shown in red
Figure 3.5 Sequence coverage ofOMP C
Shown above are the sequences of OMP C matched by experimental peptide
masses generated by trypsin digestion of protein band 2.
See appendix 2 for the sequence coverage ofOMP A and OMP F
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3.3.4 Production of Carbon-13 labelled outer membrane proteins
E. coli 018 was grown in M9 minimal medium enriched with different
amounts of carbon-13 glucose. The results in figure 3.6 show that as the amount of
carbon-13 supplementation was increased, there was an increase in the number of
isotopic peaks observed for each individual peptide species and also a change in the
intensity of the isotopic peaks relative to one another. Together, these changes
resulted in a change in the overall isotopic pattern of the peptide species. As carbon-
13 enrichment was increased from 2.3 to 3.3%, there was a corresponding increase in
the contrast of appearance of the isotopic pattern for the unlabelled and labelled
peptide. However, at the higher enrichment level of 3.3% carbon-13, there is an
observable decrease in sensitivity. This is noticeable with the peptide of m/z value
2977.5 that has disappeared into the baseline of the mass spectrogram at the 3.3%
carbon-13 enrichment level. In addition, figure 3.7 shows that at the higher
enrichment level, the isotopic envelopes of neighbouring peptides 'overlap' with one
another, making them unidentifiable as two labelled peptides. This decrease in
sensitivity and occurrence of overlapping peptides at the 3.3% carbon-13 enrichment
level was undesirable. As a consequence, enrichment with 2.3% carbon-13 was
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Fig 3.6 Determination of the optimum amount of carbon-13 enrichment of the
outer membrane proteins ofE. coli
E. coli was grown in M9 minimal medium with either (a) 1.1% carbon-13 (b) 2.3%
carbon-13 or (c) 3.3% carbon-13. The TTCF protein was then purified using a His-tag
purification procedure and the purified protein digested with trypsin. The spectra above
show four of the tryptic peptides of differing mass, which are derived from OMP F. For
each peptide, the isotopic pattern for the unlabelled peptide is compared to that
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Figure 3.7 Deleterious effect of carbon-13 labelling of proteins
Three mass spectrograms showing the isotopic pattern of two OMP F
peptides at three different levels of carbon-13 content which were a) 1.1%,
b) 2.3% and c) 3.3%
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3.4 Discussion
In the experiments within this chapter, outer membrane extracts were isolated
from three strains of E. coli and analysed using a combination of SDS-PAGE and
immunoblotting to examine their complexity and immunological relevance. These
outer membrane extracts consist of a number of proteins, phospholipids and
lipopolysaccharide (Benz 1988). E. coli was subsequently grown in carbon-13
enriched minimal medium to determine whether peptides derived from labelled
bacterial proteins could be distinguished from those derived from unlabelled proteins
and to determine the appropriate amount of labelling.
3.4.1 Outer membrane protein profiles of E. coli
The results from this study showed that there are a handful of dominantly
expressed proteins in the outer membrane of E. coli as well as a number of proteins
expressed in smaller amounts termed minor outer membrane proteins. It has
previously been determined that there are over 60 outer membrane proteins that can
be expressed by E. coli (Molloy et al., 2000). However, some of these may not have
been expressed under the growth conditions used this project and others may be
expressed too weakly to be detected using ID SDS-PAGE. The results from this
study showed that the dominantly expressed outer membrane proteins were
conserved between the three different strains of E. coli that were investigated. This is
in accordance with other studies showing that major outer membrane proteins are
conserved between different strains of E. coli and show similarities to different
members of the Enterobacteriaceae family including Salmonella and Shigella
(Hofstra and Dankert 1980; Overbeeke and Lugtenberg 1980). In contrast to the
major outer membrane proteins, differences were observed in the minor protein
profiles between the three strains of E. coli. These differences in the minor outer
membrane protein profiles may have resulted from gene mutations, leading to
proteins with slightly different sequences and thus molecular weights. Alternatively,
they may be different proteins with similar molecular weight values.
The major outer proteins in the molecular weight range 30-40 KDa were
identified as OMP F, OMP C and OMP A. These results are in accordance with other
studies that have shown the presence of these proteins in the same molecular range.
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Although the lower molecular weight proteins were not identified in this study, the
literature identifies two proteins of corresponding molecular weight as peptidoglycan
associated lipoprotein (17.5KDa) and Braun lipoprotein (7KDa). As mentioned in the
results section, it could also be the case that the lower molecular band may be the
rough form of the LPS molecule. These major outer membrane proteins play
different roles in bacterial physiology and in some cases have been implicated in
pathogenesis. Both OMP C and OMP F are general diffusion porins that are
constitutively expressed in the outer membrane. These trimeric porin structures
within the outer membrane allow the diffusion of nutrients through this otherwise
impermeable 'barrier'. Murein lipoprotein, peptidoglycan associated lipoprotein and
OMP A are all thought to play an important role in outer membrane stability and
have been implicated to play a role in sepsis (Hellman, Loiselle et al., 2000; Hellman
and Warren, 2001; Hellman, Roberts et al., 2002; Hellman, Tehan et al., 2003;
Liang, Bagchi et al., 2005). In addition, OMP A has been implicated in the
pathogenesis of meningitis in E. coli K1 and has been shown to be a target of the
host defence (Prasadarao, Wass et al., 1996; Prasadarao, Wass et al., 1999;
Belaaouaj, Kim et al., 2000; Prasadarao, Blom et al., 2002; Sukumaran and
Prasadarao, 2002; Prasadarao, Srivastava et al., 2003; Sukumaran and Prasadarao.
2003; Sukumaran, Shimada et al., 2003; Sukumaran, Selvaraj et al., 2004; Selvaraj
and Prasadarao, 2005).
3.4.2 Immunological relevance of outer membrane proteins
The immunoblots revealed that a number of the outer membrane proteins
bound to serum antibodies from healthy individuals and thus contained B cell
epitopes. However, the nature and intensity of binding varied between individuals.
Previous studies have also shown the presence of serum antibodies in healthy
humans that bind to E. coli surface proteins including OMP A, lipoprotein and iron
binding proteins (Griffiths, Yoonessi et al., 1977; Griffiths, Stevenson et al., 1985;
Henriksen and Maeland 1987). These antibodies are mainly of the class IgG and
have been found in infants of below one years of age. It has been suggested that they
are generated against gut bacteria that colonise the intestinal tract shortly after birth
(Griffiths, Yoonessi et al., 1977). The results from this study showed that serum
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antibodies from the same individuals reacted against outer membrane proteins from
different E. coli strains. Indeed, the outer membrane proteins from different strains of
E. coli and between different members of the family Enterbacteriaceae have been
shown to be antigenically cross reactive (Hofstra and Dankert 1979; Hofstra, Van
Tol et al., 1980; Henriksen and Maeland 1987). This cross reactivity initially raised
the possibility that these antigens may be useful in vaccines.
Although the serum antibodies from healthy individuals bind to a number of
the major outer membrane proteins, the strongest reactions were consistently
observed with OMP A and a protein of ~20 KDa thought to be peptidoglycan
lipoprotein. Serum antibodies appeared to react less strongly against the porin
proteins OMP F and OMP C. This may be due to more antibodies or stronger avidity
antibodies reacting with these two proteins. However, it may have also been due to
the fact that the outer membrane preparations were boiled in 2% SDS for 5 minutes
prior to PAGE. Boiling in SDS has previously been shown to denature porin trimers
into their monomeric forms. This conformational change results in antibodies that are
generated against the intact trimer binding only weakly to the denatured monomer
(Hofstra and Dankert 1979).
It was a concern in this study that antibodies binding to the outer membrane
proteins may be in fact be binding to the LPS component of tightly associated
protein-LPS complexes. The results showed that the outer membrane extracts did
contain LPS as expected and that serum antibodies from the individuals did bind to
the O antigen of the LPS molecule. Other groups have demonstrated that protein
bands excised from SDS-PAGE gels are frequently contaminated with LPS
following boiling in SDS which is not sufficient to disaggregate the complexes
(Chart and Griffiths, 1985; Rocque, Coughlin et al., 1987). Furthermore, it was
shown that methods in which detergents are used to recover the outer membrane give
rise to protein / LPS complexes which react with serum antibodies (Poxton et al.,
1985). These observations mean that one must consider that serum antibodies may be
binding to the LPS component of these complexes. Although this was not examined
further in this study, similar studies have used different methods to determine the
effect of LPS prior to examining the antibody response to outer membrane proteins.
This includes destruction of the protein component by treatment with proteinase K
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(Nicolle, Ujack et al., 1988; Hellman, Zanzot et al., 1997) or by preincubation of the
serum sample to remove anti-LPS antibodies (Bolin and Jensen, 1987; Henriksen and
Maeland, 1987). In these studies, it was shown that a proportion of the antibodies did
indeed bind to the outer membrane proteins and not LPS.
3.4.3 Production of carbon-13 labelled outer membrane proteins
Glucose is the only carbon source in M9 minimal medium, so the carbon-13
content of bacterial proteins can be easily adjusted by controlling the proportions of
natural glucose and carbon-13 glucose in the medium. The results confirmed that a
mere doubling in the amount of carbon-13 in the growth medium was sufficient to
lead to a detectable alteration in the isotopic pattern of peptides without leading to
deleterious effects. This is in line with previous data from the laboratory which has
shown that labelling with 2.3% carbon-13 glucose gives optimal labelling for the
recombinant proteins sGT and a3(IV)NCl (Zou, Turner et al., 2004). Although
higher amounts of carbon-13 would further enhance the distinction between
unlabelled and labelled peptides, 2.3% enrichment was chosen because higher
enrichment levels led to the occurrence of two deleterious effects. Firstly, the
occurrence of overlapping peptide clusters is increased with an increase in carbon-13
enrichment. This is due to an increase in the number of isotopic peaks for the peptide
species that led to an increase in baseline spreading. This is undesirable because it is
impossible to distinguish between a labelled peptide and overlapping peptide
clusters. In addition, carbon-13 enrichment leads to a decrease in detection
sensitivity. This is due to the total number of ion counts being spread over a larger
number of isotopic peaks for a given peptide. This is not favourable for the
identification of low abundance peptides in complex mixtures that may not be
detected at higher carbon-13 enrichment levels due to decreased sensitivity.
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Chapter 4 Development of a 1D and 2D nano-capillary liquid
chromatography system for the separation of complex peptide mixtures
4.1 Introduction
The work described in the previous chapter indicated that carbon-13 labelling
of bacterial antigens was feasible and enormously promising, but revealed a serious
shortcoming. It was apparent that labelled peptides are not discernible in overly
complex spectra due to the presence of overlapping peptide species. Therefore, the
principal aim of this work was to develop a separation technique that allowed the
detection and recognition of isotope patterns for peptides at picomole levels in
complex mixtures. However, it was a concern that a single dimension separation
technique might have insufficient resolution to overcome the problem. In addition, it
was also a concern that the ionisation technique proposed to be used, MALDI-MS,
could be susceptible to suppression of peptide signals in overly complex spectra. As
a result of these two factors, it was reasoned that successful use of carbon-13
labelling within highly complex samples would require a very efficient separation
system prior to mass spectrometric analysis. It was anticipated that ID separation
would prove inadequate at such a task and therefore it was envisioned that a 2D
system would need to be developed.
The most promising technique at the initiation of this project for resolving
and detecting peptides at picomole levels in complex mixtures was 2D nano-flow
liquid chromatography. Two-dimensional chromatography involves the sequential
application of two orthogonal chromatographic steps, that is to say, separation
according to two independent chemical properties of peptides. In the first dimension,
ion exchange chromatography (IEX) is employed to separate the peptides based upon
cationicity (net positive charge). This is followed in the second dimension by




•To develop a 2D nano-flow LC system capable of separating complex mixtures of
picomole amounts of peptides.
•To determine whether a 2D nano-flow LC system leads to better separation
compared to a ID nano-flow LC system by comparing the number of peptides co-
eluting at each retention time, the occurrence of overlapping peptides in individual
fractions and the total number of detectable peptides following separation.
4.3 Results
4.3.1 Set-up of the nano-flow LC system
This project initially opted to use a fully automated nano-flow LC system that
is shown in figure 4.1a. In this system, peptides were separated using either a single
or multidimensional separation technique. During single dimensional
chromatography, the peptides were separated by reverse phase chromatography (ID
RP) alone. In contrast, during multi-dimensional chromatography, peptides were
initially separated by IEX chromatography followed by reverse phase separation (2D
IEX-RP) in the second dimension.
During 1D-RP separations, the sample is loaded by an autosampler onto the
capillary trap. The capillary trap is then switched in line with the capillary flow path
of a C18 (15cm x 75pm) RP column (LC packings, USA) and the peptides
subsequently eluted by an increasing gradient of ACN. These eluted peptides pass
through a UV detector, are mixed 1:1 with matrix solution and then directly
deposited upon a 400 well MALDI-plate for mass spectrometric analysis (figure lb).
A splitter system is used to obtain a flow rate of 200 nl / minute which passes
through the RP column. The matrix pump is also set at a speed of 200 nl / minute,
collecting a total of 400 nl / minute in each MALDI-MS fraction. During 2D IEX-RP
separation (shown in figure 4.2), the peptides are initially injected by an autosampler
onto a Magic Bullet ion exchange column (Michrom BioResources, USA). Peptides
are subsequently eluted from the column in a stepwise manner using salt 'plugs' of
increasing concentration of NH4OH. Salt-eluted peptides are trapped onto a RP
capillary trap (LC packings) which is then switched in line with a capillary RP
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column. A 10 port 2-position valve that is shown in figure 4.3 controls the switching
of this capillary trap into the flow path of the RP column. The switching of this valve
from one position to another changes the flow path of the LC system. Following RP
separation, eluted peptides subsequently pass through the UV detector and are
deposited upon a 400 well MALDI-plate.
Peptide losses were a major concern, particularly moving from ID RP to 2D
separation. Several modifications were made in an attempt to minimise losses. The
system was designed to have a very small wetted area and automated fraction
collection was developed so that peptides were deposited directly onto a MALDI-MS
plate after elution from the RP column and UV detection.
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Figure 4.1a. Set-up of the nano-flow RP LC system
Photo showing the different components of the nano-flow LC system set up in the
laboratory. The system consists of several 'online' components including a pump,
sample stage, autosampler, UV detector, and sample stage for automated sample
collection.
Legend
A: HPLC pumps B: Sample stage C: Autosampler D: Injection valve E: UV
detector F: collection stage with MALDI MS plate G: matrix pump H: computer I:
Capillary trap J: RP capillary column.
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Figure 4.1b Photo showing automated fraction collection onto a 400
well MALDI MS plate.
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Figure 4.2 Set up of the 2D nano-flow LC system using the 'salt plug'
method
The sequences of events are described below:
a) Autosampler injects peptide sample onto the cation exchange (IEX)
column followed by a salt plug.
b) Eluted peptides are 'caught' on a capillary trap.
c) Capillary trap switched inline with the CI8 capillary RP column by a 10-
port 2-position valve and RP separation carried out.
d) Following a RP run, a second 'salt plug' in injected onto the IEX column
to elute a different population of peptides and a RP separation is
subsequently carried out as described in (b) and (c).
e) The method continues until the salt plug of the highest salt concentration
has been injected.
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Standby position Active position
Figure 4.3 Different flow paths of the nano-flow LC system
Shown above are 2 photos of the 10 port, 2 position valve in its different positions
In the standby position of the valve, the capillary trap is out of the ACN flow path.
This allows peptides in the sample to be caught by the trap for concentration and
desalting. In the active position of the valve, the capillary trap is switched in line
with the ACN gradient, allowing peptides to be eluted from the trap and caught
upon the RP column for separation.
Legend:
Blue arrows: path of sample
White arrows: path ofACN gradient
A: Position of entry of sample into the valve (from IEX column)
B: Position of entry ofACN gradient into the valve
C: Exit of gradient and sample from the valve (to RP column)
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4.3.2 System sensitivity
Once the nano-flow LC system had been set up, the sensitivity of the system
was examined using a number of synthetic peptides shown in figure 4.4. The
synthetic peptides used in these experiments are described in section 2.3.2 in the
methods and materials chapter. Decreasing amounts of synthetic peptides were
injected into the nano-flow LC system and separated using reverse phase
chromatography. The results showed that the system was highly sensitive, being able
to detect 5-10 picomoles of peptides in the mixture. At this level, peptides were also









Figure 4.4 Sensitivity of the nano-flow LC system
Absorbance was measured at a wavelength of 214 nm. Different amounts
of calibration mixture 2 were injected into the nano-HPLC system to
determine whether the system could detect picomole amounts of peptide.
Calibration mixture 2 contained the following synthetic peptides at
different concentrations in the final mixture: Angiotensin I (2.0
pmole/pl), ACTH clip 1-17 (2.0 pmole/pl), ACTH clip 18-39 (1.5
pmole/pl), AC1H clip 7-38 (3.0 pmole/pl), and bovine insulin
(3.5pmole/ pi). The amounts injected were as follows (i) 40 pi, (ii) 20 pi,
(iii) 10 pi, (iv) 5 pi.
93
4.3.3 One and 2D nanoflow liquid chromatography separation of the outer
membrane proteins
The goal was to resolve mixtures of labelled and unlabelled peptides, such
that the distinctive isotope pattern of labelled peptides was discernable in MALDI
mass spectrograms. To achieve this, it was decided that the resolving capability of
the nano-flow LC system should be evaluated using the complex peptide mixture
obtained by the tryptic digestion of E. coli K12 outer membrane proteins which is
shown in figure 4.5. The unseparated tryptic digest is extremely complex, with many
overlapping peptide species. The experiments were designed to investigate whether
the new 2D nano-flow liquid chromatography system could efficiently separate out
the tryptic digest of E. coli outer membrane proteins, thus preventing the occurrence
of overlapping peptide species during mass spectrometric analysis. During 2D IEX-
RP separation, the peptides were initially separated into 5 pools by elution from a
strong cation exchange column with 'plugs' of increasing salt concentration, and the
peptide pools subjected to reverse phase separation. In order to assess the capability
of the 2D IEX-RP nano-flow liquid chromatography system compared to ID RP
chromatographic techniques, the tryptic digest of E. coli outer membrane proteins
was also separated using a ID RP nano-flow liquid chromatography system, in which
the peptides were separated using only RP chromatography. The 1 and 2D
separations were compared by determining:
1) The number of peptides co-eluting into fractions collected at equivalent retention
times during both a ID RP separation and a 2D IEX-RP separation. This is a measure
of the complexity of the samples for MALDI-MS analysis.
2) The frequency of overlapping peptide ion clusters.
3) The total number of identified peptide species as a measure of the completeness of
the peptide analysis and of ion suppression.
The results from these experiments are summarised in table 4.1.
The UV chromatograms from the ID RP separation of the outer membrane
protein digest shown in figure 4.6a reveals that the peptide elution profile is very
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complex, with only partially resolved and overlapping peptide species. This is
indicative that many peptides are co-eluting at the similar retention times. This was
confirmed by mass spectrometric analysis, an example of which is shown in figure
4.7a. Similar analysis of other spectra revealed that between 10 and 30 peptides
typically eluted in each fraction (table 4.1). Mass spectrometric analysis of all of the
LC fractions revealed that there were 204 peptides detected in total in the fractions
collected from the ID RP separation. Mass spectrometric analysis of 20 selected
fractions revealed the presence of 10 overlapping clusters. In comparison, the UV
tracings from the 2D IEX-RP separation are less complex with better resolution of
peptide species (figure 4.6b). This was confirmed by mass spectrometric analysis
which showed that there were typically 5-15 peptides per fraction (figure 4.7b). Mass
spectrometric analysis of all of the LC fractions identified 214 peptides in total (table
4.1). The 1M salt sample was not analysed due to loss of the sample during the
experimental procedure. Importantly, only 1 overlapping peptide cluster was











Figure 4.5 Mass spectrogram of a tryptic digest ofE. coli outer membrane proteins





Figure 4.6 ID RP & 2D IEX-RP HPLC separation of a tryptic digest of outer
membrane proteins
(a) UV tracing from the ID separation of the outer membrane protein digest, (b) UV
tracings obtained from the 2D separation of the outer membrane protein digest.
Legend
Star above fractions: HPLC fraction shown in figure 4.7
Dash below fractions: Fractions analysed in each run for overlapping peptides (numbers












































Figure 4.7 Mass spectrometric tracings from fraction number 30
following separation of a tryptic digest of E. coli outer membrane
proteins
(a) Fraction 30 from the ID RP separation of a tryptic digest of outer
membrane proteins (b) Fraction 30 from the lOOmM salt step in the 2D












1D RP LC 10-30 10 204
2DIEX-RP LC 5-15 1 >214***
Table 4.1 Comparison of peptide separation and identification of
labelled species following ID and 2D HPLC separation
Legend
* Total number ofpeptides estimated by using the Voyagcr-DE PRO
software to estimate the number of peptides in each HPLC fraction.
** Number of overlapping peptides counted in the HPLC fractions analysed
for the ID and 2D separation.
*** 1M salt plug not analysed due to loss of sample
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4.3.3 Technical difficulties
Establishment of the nano-flow LC system and subsequent experiments
carried out using the system was impeded by a number of technical difficulties that
are summarised in table 4.2. These technical problems led to these experiments
taking several months to complete. A recurrent problem was the presence of leaks
and blockages that were hard to find in the system because of the low flow rates
employed. There were also considerable difficulties in establishing correct
synchronisation between the many different components of the system. In addition,




System development Learning curve to use
software
Takes time to be able









(e.g.) Pump system Pumps stop working
during an LC run




















Leads to peptide losses
Table 4.2 Problems encountered using the nano-flow LC system
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4.4 Discussion
The experiments in this chapter were carried out to test whether the 2D nano-
flow liquid chromatography system developed in the laboratory could improve the
separation of complex peptide mixtures compared to conventional ID
chromatography sufficient to make carbon-13 labelling work for complex mixtures.
At the initiation of this project, nano-flow LC was cutting edge technology, with
limited published information on the best set-up to use in experiments. IEX followed
by RP chromatography was chosen because they are largely orthogonal with respect
to peptide properties, and well established chromatographic procedures for the
separation of peptides. A number of other important issues had to be addressed
during system development. These are discussed below.
A Magic Bullet strong cation exchange column was chosen for the first stage
of separation. However, there are different types of CI8 reverse phase column
available to buy that differ in their dimensions, loading capacities and sensitivities. It
was important that a column with a small internal diameter was used in order to
maximise sensitivity of analysis. However, this was at the expense of reducing the
amount of sample that could be introduced into the system, increasing analysis time
and considerably increasing the difficulty in operation. The chosen compromise was
a CI8 column of 15cm in length and 75pm in diameter made by LC Packings. This
column required a flow rate of about 200nl per minute, but at the initiation of this
project, pump systems on the market could only pump at flow rates down to 50pl per
minute. Therefore, it was necessary to install a flow splitter to obtain a flow rate of
200nl / min. The use of a splitter is not an ideal way to achieve low flow rates
because the splitting ratio varies during the course of a run as the viscosity of the
flow changes. This results in changes in the rate of flow that adversely influences
fraction collection. Plus, slight blockages in the system result in the redirection of
flow to waste as a consequence of an increase in backpressure. Difficulties in
operating a splitter system were such that with the advent of pumps able to pump
200nl/min directly, the splitter has been a vital element in the system to be replaced,
as happened soon after the end ofmy project.
The next important decision was to choose whether IEX and RP
chromatography would be carried out sequentially 'online' or whether they would be
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carried out as two separate experiments. This in turn would influence the decision of
whether to use 'salt plugs' or a 'continuous salt gradient' to elute peptides from the
ion exchange column prior to reverse phase separation. An online system is faster
and requires samples to come into contact with fewer surfaces, potentially reducing
analyte losses. Thus, the concern of peptide losses between ID and 2D separation
would be reduced. The disadvantage was the greater complexity of the
instrumentation and control software, and the lower efficiency of ion exchange
separation achieved by salt plugs compared to salt gradients (Nagele et ah, 2004). On
line salt plugs were used in these experiments but in later experiments, the system
was switched to using sequential analysis to improve the ion exchange separation
achieved.
The results obtained in this study from the ID RP and 2D IEX-RP LC
separation of the outer membrane protein digest revealed that the 2D nano-flow LC
system significantly improved separation of the complex peptide mixture and the
subsequent identification of labelled peptides, without unacceptable peptide losses
but at considerable cost in effort and time. There was also an increase in the total
number of detectable peptides following 2D separation. This is likely to be the result
of fewer peptide species co-eluting in a single fraction and consequent reduced
potential for ion suppression effects. In fact, it was thought that the true number of
peptides in the 2D run was probably greater than that observed. This was because the
tinal 1M salt plug sample was unable to be analysed due to loss of the sample during
purification.
For both 1D-RP and 2D IEX-RP separation, the UV tracings underestimated
the total number of peptides detected by mass spectrometric analysis. For example,
the UV tracing for the ID separation of the tryptic digest shows that there are maybe
between 20-30 peaks. However, mass spectrometric analysis revealed that there were
in fact over 100 peptide species. This observation was also made for 2D separation,
indicating that the addition of more salt steps may have better optimised 2D
separation. Improving separation may potentially have the benefits of detecting a
larger number of peptide species by overcoming ion suppressive effects and also
preventing the occurrence of overlapping peptide clusters altogether. Indeed, 10 salt
steps were used in the bulletin published by Michrom Biosciences, USA. This study
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opted for fewer salt steps because of the many technical difficulties experienced at
this time. In addition, although the employment of more salt steps leads to better
separation, it also leads to diminishing returns in terms of the number of peptides
detected, longer experiments and more spots to analyse.
The observation that a greater total number of peptide species was observed
after 2D separation, suggested that any additional peptide losses was more than
mitigated by improvements in mass spectrometry. There was, however, scope for
improvement as it was observed that many peptides eluted over several salt steps,
diluting some peptides into several fractions with a consequent decrease in sensitivity
of analysis. Nagele et al., 2004 has reported the same deficiency using the salt plug
approach. Their solution was to design a liquid chromatography system that uses a
semi-continuous salt gradient and two capillary entrapment columns, alternatively
switched from the ion exchange effluent to the injection loop of a second dimension
RP column. The time it might take to establish a two-enrichment column system was
a concern, so in later experiments it was decided to use an off line continuous salt
gradient system to further improve resolution.
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Chapter 5 Identification of carbon-13 labelled tetanus toxin C fragment
derived peptides following in-vitro lysosomal digestion
5.1 Introduction
The aim of the experiments in this chapter were to (i) validate the carbon-13
labelling technique in complex biological mixtures and to (ii) identify any peptide
species generated from TTCF following digestion with lysosomes. The results may
help in identifying enzymes apart from AEP that may be important in antigen
digestion of TTCF and liberation of known T cell epitopes.
The results in the previous chapter revealed that the digest of E. coli outer
membrane proteins was very complex, presumably consisting of many peptides
derived from a wide range of proteins present within the outer membrane. Since
lysosomal extracts are themselves complex mixtures, it was decided that it would be
more favourable to initially examine the processing of a purified single protein such
as TTCF rather than another complex mixture. The 47-KDa carboxy-terminal
domain of tetanus toxin was chosen for several reasons. Firstly, it can be easily
produced in large quantities as a correctly folded recombinant antigen. Secondly,
there is a lot known about TTCF in respect to antigen processing and presentation.
Studies have identified a number of T cell epitopes within tetanus toxin (Demotz, et
al., 1989; Ho, Mutch et al., 1990; Reece, et al., 1993; Raju, et al., 1996; Diethelm-
Okita, et al. 1997; Diethelm-Okita, et al., 2000) and the initial processing steps of
TTCF have already been elucidated (Manoury, et al., 1998). These studies provide a
groundwork of knowledge for this study to build upon before going on to study less
well-characterised antigens.
Due to inadequacies in the 2D separation procedure carried out in the
previous set of experiments, the system was changed for the experiments discussed
in this chapter and is shown in figure 5.1. Peptide mixtures would be injected onto a
cation exchange column and eluted into several fractions using a continuous salt
gradient. The fractions would then be pooled according to complexity and separated
by RP chromatography. In order to minimise potentially greater losses of an off line
second dimension, thought was given to the handling of the first dimension fractions.
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Figure 5.1 Set-up of the revised 2D HPLC system
(a) Diagram of the first dimension of separation, in which peptides are
initially eluted from the IEX column using a continuous salt gradient and
a number of fractions collected for reverse phase chromatography, (b)
Diagram of the second dimension of separation, in which the sample is
injected onto a capillary trap that is then subsequently switched in line
with the RP column.
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5.2 Objectives
• To produce carbon-13 labelled recombinant-TTCF (r-TTCF).
•To isolate functional lysosomes from EBV transformed Pala lymphoblastoid B
cells.
• To confirm the major fragments of TTCF generated by lysosomal processing and to
further identify any small (<3KDa) TTCF peptides generated by digestion.
•To thereby validate the carbon-13 labelling and purification strategies
5.3 Results
5.3.1 Production ofCarbon-13 labelled TTCF
TTCF was expressed in carbon-13 supplemented minimal medium following
induction with 0.2 mM IPTG. The results show that the expression ofTTCF is under
tight regulation, with TTCF not being detectable prior to the addition of IPTG (figure
5.2). This allowed practically all of the recombinant protein to be labelled by the
addition of carbon-13 glucose at the time of induction. Tryptic fragments of TTCF
enriched with 2.3% carbon-13 were distinguishable from their unlabelled
counterparts throughout the m/z range 400-3000 Da (figure 5.3). A final yield of 5
mg / L was obtained following expression of the recombinant protein in M9 minimal









Figure 5.2 Expression of TTCF in M9 minimal medium
The TCP from the induced and uninduced bacterial cultures was run out on a
12% SDS-PAGE gel. E. coli expressing TTCF was grown to an OD55o value
of 0.5-0.6 and TTCF production induced by the addition of 0.2 mM 1PTG.
The culture was harvested after 3 h and 10 pi of the total cell protein from
both the uninduced and induced bacterial cultures analysed by SDS-PAGE
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Figure 5.3 Carbon 13 enrichment of TTCF
The isotopic pattern for 3 TTCF tryptic peptides of differing m/z value is shown for a)
The un-enriched peptide species containing 1.1% carbon-13 that is the natural
abundance of carbon-13 found in nature and b) Following enrichment with 2.5%
carbon-13
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5.3.2 Production of lysosomes
Lysosomes were purified from human lymphoblastoid B cells and separated
by density gradient centrifugation. The fractions containing lysosomes were
determined using a fluorescent enzyme assay detecting the activity ofN-acetyl-P-D-
glucosaminidase (figure 5.4). This enzyme acts upon the substrate 4-
methylumbelliferone to release the fluorescent compound, umbelliferone and was
chosen because N-acetyl-P-D-glucosaminidase is active only in terminal lysosomes
(Casciola-Rosen and Hubbard 1991). Results from the assay revealed that the highest
umbelliferone counts were consistently given by fractions 3 to 5, with lower counts
being observed in fractions 6 to 10. In all cases, the first 10 fractions were pooled
together and subsequently used in digestion assays. Using a protein assay, it was
o










Figure 5.4 Determination of lysosomal fractions following sub-cellular
fractionation of B cells on a 27% percoll gradient
Three millilitres of 106 / ml of broken B cells were applied to a 27% percoll
gradient and centrifuged for lh at 23,000 rpm to separate sub-cellular organelles
based upon their density a) Graph to show which fractions contained lysosomes by
measurement of N-acetyl-P-D-glucosaminidase b) Photo showing the sub-cellular
components of B cells following percoll separation. Lysosomes, as determined in
the enzyme assay, are denoted.
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5.3.3 Lysosomal digestion of TTCF
TTCF was digested in-vitro using increasing amounts of lysosomal lysate
(Figure 5.5). The results revealed that lysosomal digestion of TTCF yielded five
large fragments distinguished in a Coomassie-stained 16% tris-tricine gel. These
larger fragments persisted following digestion with the highest amounts of
lysosomes. To study the lower molecular weight digestion species (<3KDa) not
detectable using SDS-PAGE, a large scale two stage experiment was set up in which
50 pg of TTCF was initially digested at pH 5.5 for 4 h and then subsequently at the
lower pH 4.5 for a further 4 h (figure 5.6a). The decrease in pH was carried out in an
attempt to reflect acidification observed in the endosomal pathway. Lower molecular
weight digestion products were extracted by ultrafiltration over a 3KDa cut off
membrane and examined by MALDI-TOF. They comprised of an extremely complex
mixture of peptides with m/z values between 500-1500 Da (figure 5.7a). This
corresponds to peptides between 5 to 15 amino acids in length. Therefore, as well as
the large fragments seen on SDS-PAGE, the lysosome - TTCF digests contained a
highly complex mixture of low molecular weight peptides.
To investigate whether any of the low molecular peptides were TTCF
derived, the digestion extracts were separated using 2D IEX-RP chromatography and
analysed by MALDI-TOF. Disappointedly, although there were lots of different
peptides, MALDI-TOF signals were weak. This result was surprising as the amount
of TTCF used in the experiment was such that TTCF peptides should be detectable.
One reason for non-detection could be the high stability of the larger fragments and
consequent slow production of smaller fragments that could be detected by MS
analysis. Another could be rapid destruction of any released peptides. The
experiment was therefore repeated using more antigen (500 pg) and a shorter
digestion time (figure 5.6b). Analysis of the unseparated digestion products by
MALDI-MS revealed abundant quantities of hundreds of peptides with slightly
higher m/z values than the preceding, longer duration digestion experiment. Most
peptides had m/z values in the range 1000-2500 Da (figure 5.7b), corresponding to
peptides of 10 to 20 amino acids in length. Peptides in this range are substrates for















Figure 5.5 Digestion ofTTCF with increasing amounts of lysosomes
TTCF digestion products were separated using a 16% Tris-Tricine gel. a)
lOpg of TTCF was digested with 0.5- 2pg of lysosomes purified from EBV-
transformed lymphoblastoid B cells (PALA B cells). Digestion products are












Figure 5.6 Digestion of TTCF using different digestion parameters
In all digestion experiments described below, the equivalent of lOpg is analysed
using a 16% Tris-Tricine gel. a) In the first experiment, 50pg of TTCF was
digested using 20 pg of lysosomes for (i) 4h at pH 5.5 and then for a further (ii)
4h at pH4.5 with the addition of 2pg of fresh lysosomes. b) In a second








Figure 5.7 MALDI-MS analysis of unseparated digestion products following
lysosomal digestion of TTCF
Mass spectrograms of peptides in the m/z range 400-2500 Da are shown for the
unseparated digestion products following a) the 8h digestion period shown in 5.5a
(ii) and b) the 4h digestion period shown in 5.5b. For both samples, the digestion
mixture was passed initially through a 3KDa cut-off filter (Amicon). A small
proportion was subsequently concentrated and desalted using a CI8 Zip™ Tip, and
analysed by MALDI-TOF MS to give the mass spectrograms shown above. The MS
conditions under which spectra were collected and processed were the same for
both samples.
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5.3.4 Analysis of peptides <3000 Da recovered from lysosomal digests of TTCF
The peptide mixture was highly complex so it was decided that 2D IEX-RP
separation would be employed to generate a large number of less complex fractions
for analysis. UV tracings from the 2D IEX-RP separation contained large numbers of
partially resolved peaks (figure 5.8). However, separation was fairly successful in
that mass spectrometric analysis of the fractions revealed between 20 and 100
peptides at which complexity, ion suppression and overlapping clusters should be
less frequent.
After extensive examination of the spectra, two peptides were identified as
having a carbon-13 'labelled' isotopic appearance (figure 5.9 & table 5.1). Several
other isotope clusters could have been labelled or accounted for as overlaps. The m/z
of the putative TTCF derived peptides each matched the predicted m/z of several
TTCF subsequences. More precise measurement of m/z values using internal
standards is often sufficient to distinguish the correct sub-sequences (Zou et al.,
2003). However, this approach was unsuccessful here because the putative TTCF
derived peptide ions were of too low abundance to be seen in spectra that included
internal peptide standards. The best that could be achieved was a close external
calibration which gives rise to much larger errors between the experimental and
predicted peptide m/z values.
The peptide of mass 2208Da matched to three TTCF sequences whilst the
peptide ot mass 2060.1 matched to two TTCF derived sequences. All predicted
matches for both of these peptides matched to peptides of 17 to 19 amino acids in
length, which is within the characteristic size for peptides eluted from MHC class II
molecules. These matches are shown superimposed upon the TTCF sequence in
figure 5.10. None of these candidates matched to previously elucidated cut sites for
enzymes implicated in antigen processing of TTCF or to known T cell epitopes
(Hewitt et al., 1997; Manoury et al., 1998). Overall, these results indicated that lower
molecular weight TTCF fragments can be identified from their labelled appearance
but are surprisingly scarce in the lysosomal digest, despite the vast relative
abundance of TTCF in the digestion mixture which was present at least 10 times the
amount of any other protein.
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Figure 5.8 2D IEX-RP nano-flow LC separation of digestion products following
lysosomal digestion of TTCF
a) UV tracings from the RP separation of the 5 IEX fractions obtained from IEX
separation of the lysosomal digestion products, b) Mass spectrograms of 3 HPLC


































Figure 5.9 Identification of a peptide with a carbon-13 'labelled' isotopic
appearance following 2D IEX-RP nano-flow LC separation of the digestion
products obtained from lysosomal digestion of TTCF
a) MALD1-TOF MS analysis of fraction 30 from the RP separation of IEX Fr 4 b) Mass
spectrogram of fraction 30 showing a peptide with a m/z value of 2008.1 which was
identified as having a 'labelled' isotopic appearance. There are two other potentially
labelled peptides in the spectra, one of which is most probably accounted for by an
overlapping peptide cluster and the other of which is too weak to determine whether it is
a labelled peptide, c) Mass spectrogram of a peptide of similar m/z value of 2034.1,

















Table 5.1 TTCF derived sequences that could account for the 2 identified
labelled peptides
The masses of the 2 peptides with a labelled isotopic appearance were searched
against a list of calculated prelisted m/z values for all possible subsequences ofTTCF.
The maximum error allowed between experimental and predicted masses was














Figure 5.10 TTCF sequence matches for the two peptides identified
as having a carbon-13 labelled isotopic appearance
The TTCF sequences which matched by mass (+/- lOOppm) to the
peptides identified as having a labelled isotopic appearance are shown
by lines above (for 2060) or below (for 2208) the sequence of TTCF
denoted in single letter amino acid code. A histidine tag
MGHGHHHHHHHHHHSSGHIEGRHI precedes the TTCF sequence.
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5.3.5 Digestion of TTCF with different subcellular fractions
One concern was that the scarcity of lower molecular weight digestion
products might be a consequence of unintended selection of subpopulations of
processing compartments that did not contain all of the enzymes required to digest
the larger TTCF fragments into lower digestion products. Alternatively, the selected
population may have contained too many enzymes. It is known that early endosomes
mature into late endosomes and eventually fuse with lysosomes. During this
maturation, there is a gradual decrease in pH from 6.5 to 4 with an accompanying
increase in enzyme activity.
To examine the TTCF processing capacity of endo / lysosomal organelles of
different density, TTCF digestions were set up using different sets of fractions from
the separation of the subcellular components of B cells (figure 5.11). The results
revealed that digestion of the parent TTCF molecule is seen with the pooled fractions
1-7, 8-10, and 11-13. Conversely, no digestion was observed using fractions 14-25.
In digestions using fractions 1-13, the same large digestion fragments were
detectable using a 16% tris-tricine gel. However, it appeared that digestion became
progressively weaker going from fractions 1-7 to 11-13 and importantly no
















1 3 5 7 9 11 13 15 17 19
Fraction number







Figure 5.11 Digestion of TTCF using different fractions obtained by
the percoll based fractionation of sub-cellular organelles from broken
B cells
(a) Shows umbelliferone counts for subcellular fractions of B cells
obtained by percoll based separation of homogenised B cells, (b)
Fractions were pooled together according to their N-acetyl-P-D-
glucosaminidase activity (shown in a) and lOpg of TTCF digested using
different 'pooled' fractions. The digestion products were separated using
a 16% Tris-Tricine gel. Arrows denote digestion products.
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5.4 Discussion
In the experiments described in this chapter, the aim was to identify carbon-
13 labelled TTCF digestion products following in-vitro digestion with lysosomes
isolated from EBY transformed B cells. It was demonstrated that carbon-13 labelled
TTCF could be successfully expressed in M9 minimal medium at quantities
sufficient for use in such large-scale experiments. Lysosomal preparations were also
successfully purified by a combination of cell homogenisation followed by Percoll
based density centrifugation to separate the subcellular components (Davidson et al.,
1990). This method was chosen because it was previously used by Manoury et al.,
(1998) to isolate lysosomes for in-vitro studies in studying the initial digestion steps
of TTCF.
The problem of identifying low molecular weight (800-4000 Da) TTCF
digestion products was tackled by using 2D nano-flow liquid chromatography to
separate out the complex digestion mixture prior to characterisation of the processing
products by MALDI-MS. In the large-scale digestion experiment in which 500 pg of
TTCF was digested by lOOpg lysosomes, the peptides ranged from between 10 to 20
amino acids in length. These are the sizes of peptides eluted from MHC class II
molecules and encouraged the search for TTCF fragments. However, only two
peptides were finally identified as having a labelled isotopic appearance. It was
hypothesised that few TTCF peptides may have been identified because not all of the
processing compartments required for complete digestion were used in the in-vitro
experiments. However, digestion using other subcellular compartments did not lead
to more complete digestion. The observation that digestion became progressively less
extensive going from fractions 1-13 is consistent with the idea that harsher digestion
occurs in lysosomes and late endosomes (most dense fractions) compared to earlier
endosomes (less dense fractions).
It should be noted that both of the peptides identified as being labelled
peptides were present in complex fractions containing up to 100 peptides so it is
possible that they were part of overlapping peptide clusters that resembled a labelled
peptide. In addition, both peptides gave rise to weak signals of below one thousand
ion counts during mass spectrometric analysis, which decreases the certainty of
distinguishing labelled peptides. The weak signals obtained for each of the peptides
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meant that the peptides could not be further characterised by more precise m/z
measurement of sequencing. Confirmation of the peptides would require the
experiment to be repeated on a larger scale and sequence analysis by tandem mass
spectrometry.
Possibly, an alternative lysosomal isolation technique may have improved the
experiment by reducing the complexity of the lysosomal autolysis mixture. In the
method used in this study, the detergent CHAPS was used to solubilise the lysosomal
membrane prior to digestion. Thus, proteins from the lysosomal membrane may have
been solubilised and contributed to background peptides. An alternative method to
isolate pure lysosomal enzymes uses a combination of differential centrifugation and
hypotonic lysis of lysosomes (Schroter et al., 1999). In this method, the lysosomes
are burst open by the addition of water and subsequently removed by centrifugation.
Pure lysosomal enzymes are then recovered by a second centrifugation step. Using
this technique, which would lead to improved separation and less complex fractions,
may significantly reduce background mess.
The principal conclusion that TTCF low molecular weight peptides are scarce
was challengeable because the sensitivity of the carbon-13 labelling technique in
biological extracts has not been determined. Previous to this project, the carbon-13
labelling technique had been shown to be highly sensitive and specific in controlled
mixtures of labelled and unlabelled peptides (Zou et al., 2004). In these mixtures, the
relative abundances of labelled peptides were higher and the peptide mixtures less
complex than those examined here. In addition, the high laser intensity required to
detect the peptides in many fractions led to a noisier baseline than that usually
observed with more concentrated samples. It may therefore be the case that the
carbon-13 labelling technique can not be used to identify low level peptide species in
peptide mixtures of such complexity The experiments in the following chapter were
set up to test this hypothesis.
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Chapter 6 Identification of tetanus toxin C fragment-derived carbon-13
labelled peptides in complex peptide mixtures
6.1 Introduction
In the experiments in this chapter, the sensitivity of the carbon-13 labelling
technique in identifying carbon-13 labelled TTCF peptides in complex mixtures was
tested. It was decided to test sensitivity independent of digestion by 'spiking' pre-
digested TTCF peptides firstly into a peptide mixture and then into lysosomal
digests. The experiments were prompted by data from the previous chapter in which
TTCF derived peptides were unexpectedly scarce when assessed by 2D IEX-RP
nano-flow HPLC and MALDI-TOF. The decision was made to separate the mixtures
in the proceeding set of experiments using ID chromatography in preference to 2D
analysis in order to reduce the amount of data to analyse and thus the time scale of
the experiment.
6.2 Objectives
• To characterise carbon-13 labelled TTCF peptides generated by trypsin digestion.
• To examine the effectiveness of carbon-13 labelling at identifying TTCF peptides
spiked at low relative abundance into complex peptide mixtures generated by trypsin
digestion of 3 proteins.
• To compare the effectiveness of carbon-13 labelling at identifying TTCF peptides
spiked at low relative abundance into lysosomal extracts that have been permitted to
autolyse for 4 h at 37 °C and contain a complex mixture of peptides and other
lysosomal constituents.
6.3 Results
6.3.1 Characterisation of tryptic fragments of labelled TTCF derived peptides
The m/z values of peptides generated by tryptic digest of TTCF were
measured after internal calibration against 2 autolysis peptides of trypsin. Eight of
these peptides were identified as having a labelled isotopic appearance and matched
to a TTCF sequence following calibration (table 6.1). It was found that the peptides
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gave rise to variable signal intensities during mass spectrometric analysis, ranging
from 1000 to 10,000 ion counts. Sensitivity and specificity data showed that the
carbon-13 test was 100% sensitive; identifying all TTCF derived peptides as being
labelled (table 6.2). The test was also shown to be highly specific, with only 1 non-
TTCF derived peptide being identified as having a labelled appearance. This peptide
gave rise to a very weak ion count, which may have accounted for the error as weak
peptides often resemble labelled peptides. Five distinct ions in the mass spectrum
did not match to the TTCF sequence nor did they have a labelled isotopic
appearance. These unlabelled non-TTCF derived peptides were assumed to be from










664.3692 6000 EVR<QITFR>DLP 12
721.3956 7500 LYK<KMEAVK>LRD 5
841.4511 >10000 NGK<LNIYYR>RLY 6
1004.4970 >10000 FLR<DFWGNPLR>YDT 2
1135.5 3000 YPK<DGNAFNNLDR>ILR 1
1291.6960 700 ILR<VGYNAPGIPLYK>KME 13
1426.5169 900 IKR<YTPNNElDSFVK>SGD 5
2034.0795 900 DDK<NASLGLVGTHNGQIGNDPNR>DIL 33
Table 6.1 Characterisation of labelled TTCF peptides following trypsin
digestion
The peptide masses generated by trypsin digestion of TTCF were searched
against a list of calculated prelisted m/z values for all possible subsequences of
TTCF. An error of +/- 100 ppm was tolerated between experimental and
predicted values.
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Sensitivity = a/ (a+c) = 8/8 =100%
Specificity = d/ (b+d) = 5/6 = 83%
Table 6.2 Data showing sensitivity and specificity values for the carbon -13
labelling technique in the identification of labelled TTCF peptides following
tryptic digestion of TTCF
Sensitivity = The proportion of TTCF denved peptides which are detected as having
a labelled isotopic appearance
Specificity = The proportion of non - TTCF derived peptides that are detected as
having an unlabelled TTCF appearance.
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6.3.2 Identification of tryptic fragments of labelled TTCF in mixtures with more
abundant unlabelled peptides
To test the capacity of the technique to distinguish labelled from unlabelled
peptides, 10 picomoles of tryptic fragments from TTCF were mixed with 50
picomoles of a mixture of peptides generated by trypsin digestion of three unlabelled
proteins (figure 6.1). Mass spectrometric analysis of the unseparated mixture
identified only 1 out of the 8 TTCF fragments. This peptide had a m/z value of
1004.5 and had previously given rise to the highest ion counts in the tryptic digest of
TTCF, prior to mixing with the unlabelled peptides shown in table 6.1.
MALDI-TOF analysis of fractions following RP separation of the mixture
permitted the detection of all 8 labelled TTCF peptides (figure 6.2). The benefits of
RP separation were mostly a consequence of improved ionisation of the TTCF
peptides in less complex mixtures, with between 2-5 peptides being observed in each
fraction. In every case, TTCF derived peptide ions were identified with a labelled
isotope pattern in fractions collected at retention times identified previously to those





























































1004.49 (labelled TTCF peptide)
Figure 6.1 Identification of carbon-13 labelled characterised TTCF peptides
in a complex mixture of labelled and unlabelled tryptic peptides
a) Mass spectrogram of 10 pmoles of a tryptic digest of carbon-13 labelled
TTCF b) Mass spectrogram of 10 pmoles of the same TTCF tryptic digest mixed
with 50 pmoles of a tryptic digest of three unlabelled proteins (BSA, Hb,
chicken egg lysozyme).
Star denotes a labelled TTCF peptide of mass 1004.49 which is still detectable
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Figure 6.2 Identification of carbon-13 labelled TTCF peptides in a complex mixture of
labelled and unlabelled tryptic peptides following RP separation
a) UV tracings from the RP nano-flow LC separation of 10 pmoles of the labelled TTCF tryptic
peptides (i) alone (ii) or mixed with 50 pmoles of a tryptic digest of three unlabelled proteins.
Numbers above the tracings indicate the presence of a labelled peptide within the fraction
collected at that retention time. The identity of the labelled peptide is shown in the table next to
the UV tracings, b) Mass spectrograms for two of the fractions (Fr 23 & Fr 45) from the RP
separation of the mixture of labelled and unlabelled peptides containing the labelled TTCF
peptides 1004.5 and 2034.1 respectively. For both peptides, the bottom spectrogram in each
panel is a blow up of the peptide shown in the spectrogram above, showing its labelled isotopic
pattern.
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6.3.3 Identification of tryptic fragments of labelled TTCF in lysosome autolysis
mixtures
To test the capacity of the technique to identify labelled peptides in lysosomal
autolysis digests, 10 micrograms of lysosomes were incubated at 37°C for 4 hours,
and then spiked with 10 pmoles of TTCF and immediately injected into the HPLC
system. MALDI-TOF analysis of an aliquot taken before RP separation contained a
complex mixture in which 0 of the 8 labelled TTCF fragments were detected. The
mixture was extremely complex, containing hundreds and possibly thousands of
peptides (figure 6.3). RP separation of the mixture gave a complex chromatogram
(figure 6.4a) in which several peaks had retention times identical to 5 of the 8 TTCF
fragments. Mass spectrometric analysis identified 5 out of the 8 labelled peptides in
the fractions collected at the expected retention times, as shown for the peptide of
m/z value 2034.1 in figure 6.4bi. One of these peptides, 1135.5, was found to be part
of an overlapping cluster, preventing the recognition of the labelled isotopic pattern
(6.4bii).
It was thought that ion suppression from the sheer number of peptides in
many of the fractions may have been responsible for 3 / 8 of the labelled peptides not
being detectable following RP separation of the mixture. Indeed, all 3 of these
peptides had given rise to the weakest signals in the spectra of unmixed TTCF tryptic
peptides shown in table 6.1. To illustrate the influence of ion suppression on peptide
intensity, figure 6.5 shows the influence of ion suppression upon a single labelled
peptide with an m/z value of 1135.5. The signal for this peptide following RP
separation of the lysosomal autolysis products is compared to that obtained from the
tryptic digest of TTCF and the mixture of labelled and unlabelled tryptic peptides
before and after RP separation. From the results, it is clear that the peptide is weakly
ionised in the tryptic digest of TTCF and is barely detectable in the unseparated
mixture of labelled and unlabelled peptides. Following RP separation of this mixture,
however, there is a 100-fold increase in its intensity as a result of the reduction in
number of peptides co-eluting in the HPLC fraction. This leads to peptide 1135.5
being the dominant peptide present within the fraction. In contrast, following RP
separation of the lysosomal autolysis products, over 100 peptides co-eluted with
1135.5. This led to a 10 fold reduction in its intensity compared to that observed
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following RP separation of the less complex mixture of tryptic peptides. From these
results, it is apparent that the influence of ion suppression upon the peptides is
greatest in the more complex mixtures.
X 2009J0802
1083.0 1336.6 1590.2 1843.8 2097.4 2351.0
Mass (m/z)
Figure 6.3 Identification of carbon-13 labelled characterised TTCF peptides in
unseparated lysosomal autolysis products
Ten micrograms of lysosomes (+ lOmM DTT, 0.02% CHAPS) were digested at 37 °C
for 4 h and then the digestion products passed through a 3 KDa cut-off column. Ten
pmoles of pre-digested carbon-13 labelled TTCF (same as that used in figure 6.1) was
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Figure 6.4 Identification of carbon-13 labelled TTCF peptides in lysosomal
autolysis products following RP nano-flow LC separation
a) UV tracings from the RP separation of 10 pmoles of a carbon-13 labelled
TTCF digest (same as one used in figure 6.1) either alone (red line) or mixed
with lysosomal autolysis products (blue line) b) Mass spectrograms of 2
fractions (Fr 38 & Fr 46) from the RP separation of the mixture of TTCF
peptides and lysosomal autolysis products, (i) The mass spectrogram of Fr 38
shows peptides ofm/z value between 800-2500, with the labelled peptide of m/z
valve 2034.1 not being detectable as a consequence of ion suppression, (ii) The
mass spectrogram of Fr 46 is a blow up of the labelled TTCF peptide with an
m/z value of 1135.5, which is shown to occur in this fraction as part of an
overlapping peptide cluster.








































Figure 6.5 Influence of ion suppression upon the intensity of a labelled TTCF tryptic
peptide
Signal intensity, as measured by the number of ion counts recorded for an ion during mass
spectrometric data collection, was compared for the TTCF peptide of m/z value 1135.5 in
different spectra. The spectra were collected from:
a) The unseparated tryptic digest ofTTCF peptides alone
b) The unseparated mixture of labelled and unlabelled tryptic peptides (shown in figure
6.1b)
c) Following RP nano-flow LC separation of (b)





The experiments in this chapter were designed to examine the possibility that
the lack of peptides in the previous set of experiments was simply a consequence of
low sensitivity of the carbon-13 labelling technique. In these experiments, 10 pmoles
of TTCF tryptic peptides were 'spiked' into mixtures of differing complexity at a
relative low abundance and subsequently separated using RP chromatography. The
results clearly show that detection in MALDI is initially dependant upon the
complexity of samples. Thus, in the unseparated mixtures, the majority or all of the
labelled TTCF peptides were undetectable as a result of ion suppression. The huge
influence of ion suppression upon the intensity of peptide species in complex
fractions was further demonstrated for the peptide with an m/z value of 1135.
Importantly, it is also clear that the peptides that ionise less well and give rise to the
lowest ion counts in uncomplex samples were most susceptible to becoming
suppressed beyond the limits of detection in the complex HPLC fractions.
Following RP separation of the mixtures, all 8 of the TTCF peptides were
identifiable following separation of the simpler peptide mixture generated from the
digestion of 3 unlabelled proteins and 5 out of the 8 were detectable following RP
separation of the more complex lysosomal autolysis mixture. To ensure that the
identification of the labelled peptides was not biased due to the familiarity of the
experiments with the TTCF tryptic fragments, an individual who was unfamiliar with
the tryptic fragments was asked to identify the labelled peptides based solely upon
their isotopic pattern. This person identified the labelled peptides in the fractions
with ease.
The results considerably help the interpretation of the low abundance of
TTCF fragments in lysosomal digests of intact TTCF that was described in the
previous chapter. In those earlier experiments, much larger amounts of TTCF were
used, with up to 500 pg of TTCF being digested. This is the equivalent of 10,000
pmoles of peptides following the complete digestion of TTCF. Since the limit of
detection was shown to be below 10 pmoles in experiments in this study, other
factors must play a role to explain why few labelled TTCF peptides were identified.
Moreover, the experiments in the previous chapter employed the 2D separation
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system which was earlier shown to improve separation and identification of labelled
peptides compared to that of a 1D separation system.
Taken together, it was concluded from these results that the carbon-13
labelling technique had ample sensitivity to detect TTCF derived peptides among
peptides recovered from lysosomal digests of TTCF, as described in the previous
chapter. It is consequently concluded that small TTCF-derived peptides are
extremely scarce in lysosomes. The possible reason for this observation will be
discussed in the next chapter.
137
Chapter 7: Discussion
The experiments in this study were designed to test whether a novel 13C
labelling technique could be used to identify peptides of interest within complex
mixtures. Such a labelling technique would have broad applicability in circumstances
where it is desired to identify a protein and its breakdown products in complex
samples recovered from biological systems. The spur to development has been the
problem of distinguishing antigen-derived peptides in MHC class II or lysosome-
extracts from antigen-pulsed antigen presenting cells. These peptides are of great
interest in understanding how antigens are processed, and in rational vaccine design.
With this in mind, the ultimate goal of this project was to use the isotope labelling
technique to identify bacterial derived MHC class II associated peptides following
pulsing experiments with antigen presenting cells and bacteria.
Biochemical analysis of complex peptide mixtures is both laborious and time
consuming, often taking several months to complete. Isotopic labelling techniques
have the potential to greatly simplify analysis by making peptides of interest
distinguishable from other peptides within complex mixtures. Recently, using a
somewhat different technique, the potential of stable isotope labelling was
established by Meiring et al., (2005). In that study, bacteria were cultured in minimal
medium containing either 14NH4C1 or 15NH4C1, and then the outer membrane vesicles
(OMV) containing Por A subsequently isolated and used to pulse dendritic cells in a
1:1 ratio. The MHC class II peptides were subsequently isolated, separated by HPLC
and labelled peptides identified as 'spectral couplets' during mass spectrometric
analysis. These spectral couplets arise because of a 1.2% average increase in mass in
peptides labelled with 15N. Using this technique, they identified 10 naturally
processed and presented epitopes from the meningococcal outer membrane protein
Por A. Two of these epitopes were found to be dominantly expressed at the cell
surface and to be immunodominant CD4 T cell epitopes conserved between different
strains. Such epitopes would therefore be suitable candidates in the design of
epitope-based vaccines against infectious disease.
The technique examined in this study employed the stable isotope l3C rather
than 1 N. During development of the technique, 13C was chosen in preference to 15N
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because the natural isotope pattern of peptides is dominated by that due to the
content of 13C, so a small change in 13C content would discernibly alter the isotope
overall pattern whereas much bigger changes in 15N content would have been
required. Indeed, Meiring et al., (2005) had to make mixtures of 100% 14N and 15N to
identify labelled peptides. Thus, carbon-13 labelling would be substantially cheaper
when labelling large amounts of antigen. In addition, if the ratio of 14NH4C1 to
15NH4C1 labelled bacteria is not exactly 1:1 in pulsing experiments, this can lead to
abundance differences between spectral couplets that can make analysis more
n
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difficult in very complex mixtures. With the C technique, this is not an issue
because the mass spectra are scanned for individual peptides that have a unique
isotopic appearance to all other peptides within the spectra. However, other concerns
n
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do arise when using the C labelling technique to identify labelled peptides in
complex mixtures. Firstly, increased baseline spreading resulting from an increase in
the number of labelled peaks for a peptide species leads to the occurrence of
overlapping peptide species in more complex spectra. Secondly, the spreading of the
overall ion count for a peptide over a greater number of isotopic peaks results in a
decrease in mass spectrometric sensitivity. To minimise the influence of these two
problems, the study opted to double the 13C content of proteins.
Another important difference between the studies is the type of mass
spectrometry used to characterise peptides. Meiring et al., (2005) employed online
nLC-ESI-MS in their study whereas this project employed MALDI-TOF
spectrometric analysis. Online nLC-ESI-MS is becoming the more common method
of characterisation of class II peptides. Tandem mass spectrometry provides both MS
and MS/MS analysis of all peptides within the mixture and can detect sub-femtomole
quantities of peptides. The high sensitivity of these mass spectrometers has led to the
identification of class II peptides following nLC-ESI-MS of unfractionated class II
samples (Nepom et al., 2001; Meiring et al., 2005). Carbon-13 labelling techniques
can be successfully combined with instruments such as these. However, these
instruments are more expensive to buy / maintain and are difficult to operate.
Therefore, they are not widely accessible. In contrast, MALDI-TOF instruments are
cheaper to maintain and far easier to operate, being more accessible to many research
groups.
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One of the aims stated at the beginning of the project was to feed whole
bacteria to antigen presenting cells and subsequently identify T cell epitopes from
immunogenic antigens. With this in mind, the study initially focussed upon work
using E. coli outer membrane proteins. E. coli was chosen for use in this study for
several reasons. Firstly, the genome of E. coli has recently been sequenced,
providing invaluable information about the proteins encoded by the DNA sequence
of the micro-organism (Blattner et al., 1997). Secondly, E. coli is relatively safe to
handle in the laboratory and is easy to grow on a large scale, producing satisfactory
amounts of proteins for use in later experiments. Thirdly, E. coli is a pathogen,
causing a variety of diseases ranging from gastroenteritis to urinary tract infections
which are estimated to cause great medical and economic losses (Minino et al.,
2002). Therefore, the search for protective T cell epitopes conserved between
different strains may prove to be beneficial in the design of vaccines. Indeed, the use
of overlapping synthetic peptides has previously identified several murine T cell
epitopes in OMP F, one of which was recognised in a genetically permissive manner
by several MHC molecules (H-2 d'k'b). This epitope (OMP F 295-314) is in a
transmembrane portion of OMP F and is conserved between different porins in E.
coli (OMP C, Pho E) as well as between different species of Enterobacteriaceae,
including Salmonella enterica serovar Typhimurium, Salmonella enterica serovar
Typhi, and Shigella flexneri. It has also been shown to polarise the immune response
in mice towards a ThI response that would be desirable against intracellular
pathogens such as Shigella and Salmonella. Thus, the identification of genetically
permissive T cell epitopes within E. coli outer membrane proteins may prove to be
important in the design of peptide based vaccines.
For preliminary work, outer membrane extracts were chosen in preference to
whole bacteria in order to simplify biochemical analysis during development and
validation of the labelling technique. Initial experiments demonstrated that these
outer membrane extracts contained a number of dominantly expressed proteins,
many of which were bound by serum antibodies from a number of healthy
individuals. These outer membrane proteins were therefore considered suitable
13 •candidates for C labelling in order to investigate the presence of T cell epitopes.
However, due to the complexity of these extracts, as demonstrated by enzyme
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digestion followed by mass spectral analysis, the focus turned to validating the C
labelling technique in less complex mixtures. TTCF was selected because it was
thought that the use of one antigen in experiments would make the identification of
antigen-derived peptides an easier task and thus simplify biochemical analysis.
Attention could then be refocused upon more complex groups of antigens such as the
outer membrane proteins.
The study established that the 13C technique was broadly applicable to
labelling bacterial proteins. Labelling was demonstrated for native bacterial proteins,
specifically numerous bacterial outer membrane proteins, and for foreign proteins
IT
expressed in E. coli in the form of TTCF. In each case, C labelled peptides were
readily distinguishable from their unlabelled counterparts on mass spectrometric
IT • •
analysis. Just a doubling of the C content to give 2.3% labelling was shown to be
sufficient to produce isotopically different peptides without leading to significant
base line spreading and a decrease in sensitivity. Moreover the technique is very
economical as only a small amount of 13C enriched glucose is required to be added to
minimal media in order to efficiently label a large amount of a desired protein.
Together with previous data published from the laboratory, these results show that
1 T
the C labelling technique is applicable to a wide range of antigens that can be
expressed either as recombinant proteins or extracted from bacteria grown in
supplemented media (Zou et al., 2004). Thus, many clinically important bacterial
stiains and bacterial toxins should be easily labelled using this technique. However,
it may not be possible to label bacteria that require complex and undefined media to
grow. For these pathogens, an alternative would be to choose bacterial antigens
known to be important in virulence and produce labelled recombinant antigens rather
• •IT
than the whole organism. In addition, C does not interfere with antigen processing
and is very safe, making it a favourable alternative to radioactive labelling which is
difficult to control on a large scale and to more discrete labels (e.g. biotin) which
may become dissociated from the protein during processing or may interfere with
processing of the molecule.
Initial experiments carried out using the outer membrane proteins
demonstrated that identification of the 13C-enriched peptides critically depended on
the complexity of mass spectra during MALDI-TOF analysis because overlapping
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peptides are abundant in complex spectra. In order to minimise / prevent the
occurrence of overlapping peptides, a 2D IEX-RP nano-flow LC system was set up
in the laboratory and used to separate an enzymatic digest of E. coli outer membrane
proteins. Separation of the digest by the 2D IEX-RP nano-flow LC system led to a
reduction in the occurrence of overlapping peptides and an increase in the number of
detectable peptide species compared to ID RP nano-flow separation. This was
thought to be due to a decrease in the number of peptides co-eluting at the same
retention time, and a consequent reduction in ion suppressive effects within these
fractions. It is clear that multidimensional separation techniques will be critical in
IT# •••• • •• •
applying C-enrichment to identifying antigen derived peptides in class II peptide
pools ifMALDI-TOF MS is used. Other ionisation techniques are less susceptible to
ion suppression effects, and may be better partners to 13C labelling.
It was decided to apply the techniques first to an analysis of the peptide
intermediates generated within lysosomes. These peptides are interesting because
they would identify areas of the antigen that are released during antigenic processing
for binding to MHC class II molecules and presentation to T cells. Furthermore,
these experiments would also validate the use of the 13C labelling technique in a
complex biological system before going onto to tackle more complicated studies
analysing class II eluted peptides. Moreover, it was thought that this would be a less
challenging experiment than analysis of HLA class Il-bound peptides, because it
should be possible to ensure that labelled antigen is one of the most prevalent
proteins in the samples. Surprisingly, few 13C labelled peptides were identified
following 2D IEX-RP nano-flow HPLC separation of lysosomal processing products
(<3KDa) following the in-vitro digestion of TTCF. This was the case even when
large amounts of antigen were digested by much smaller amounts of lysosomes (5:1
ratio), and in spite of laborious and time consuming analysis. Only two peptides were
found that had isotope patterns indicative of their being derived from 13C-labelled
TTCF.
It was a concern that the scarcity of labelled processing products may be a
consequence of deficiencies in the labelling and detection systems, so the next set of
experiments were set up to define the weaknesses and sensitivity of the technique.
The principal weaknesses were that overlapping peptides occurred frequently in
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complex spectra and that many peptides with labelled isotopic appearances gave rise
to very low ion counts. Although many of these weak species had isotopic patterns
resembling labelled peptides, many unlabelled peptides can have a labelled
appearance at lower ion counts. As these fractions are quickly exhausted, it was
impossible to determine whether these species are in fact labelled. Further
experiments demonstrated that the techniques as they were applied had adequate
sensitivity to detect TTCF peptides in lysosomal digests, had they been present, as
much smaller molar quantities of pre-digested TTCF peptides (as small as ~10
pmoles) added to lysosomes were detected with efficiencies >50% employing a ID
IT •
separation strategy. These results demonstrated that the C labelling technique
combined with ID or 2D depending on complexity is suitable for detecting small
levels of peptides in complex mixtures.
Therefore, the results demonstrate that TTCF processing products are
extremely scarce in lysosomes. It has been previously demonstrated that following
digestion of radio-labelled TTCF in B cells, radiolabeled fragments are only
recovered from areas protected by bound immunoglobulin, with non-protected parts
being rapidly destroyed by lysosomal enzymes. In this study, however, in-vitro
digestion generated five larger digestion fragments detectable by SDS-PAGE that
persisted till the end of the digestion period despite a change in digestion parameters
(pH) or processing compartments used in the experiments. As a consequence, it was
thought that one reason for the lack of digestion species may have been due to the
stability of larger digestion products during in-vitro digestion and the lack of
production of smaller digestion products from the large digestion species. This may
be due to factors which are present in cells but absent from the lysosomal
compartments used during in-vitro experiments. These may include chaperones that
aid in protein unfolding. Alternatively, a proportion of these larger fragments may
have been digested into smaller peptides that were subsequently destroyed by
lysosomal enzymes.
Previous to this work, there had been publications that had indicated that
TTCF derived peptides should be detectable following in-vitro lysosomal digestion.
Firstly, Hewitt, et al., (1997) demonstrated that following the unfolding of TTCF,
there are many cut sites for the enzymes cathepsin D and E within the antigen. In-
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vitro digestion with both of these enzymes generated many species which were
detected using mass spectrometric analysis (Hewitt et al., 1997). Secondly, in-vitro
lysosomal processing has been used successfully in the identification of digestion
products (<3KD) of myelin basic protein (MBP) (Beck et al., 2001; Burster et al,
2004). It was shown that large fragments of MBP are initially detectable by reverse
phase HPLC. Over a 6hr digestion period, these larger fragments are subsequently
degraded into a number of smaller digestion products between 20-40 amino acids in
length detectable by mass spectrometry, before being finally degraded into peptides
of only a few amino acids in length and single amino acids. An important difference
may be that both Hewitt et al (1997) and Beck et al., (2001) used denatured TTCF
and MBP respectively in digestion experiments. In contrast, TTCF was not denatured
prior to digestion in this study. It is known that denaturation in the acidic endocytic
pathway is required for efficient processing of antigens and occurs in the presence of
reducing enzymes such as GILT (Jensen, 1993; Watts, 2001). It may be the case that
if TTCF had been heat denatured prior to digestion, then the large fragments may
have been digested into smaller fragments detectable by mass spectrometric analysis.
This would indicate that another factor missing from our digestion experiments
might have been a strong denaturing environment.
Based upon the results gained from this study, there are modifications that
could be made to improve the experiment. As already mentioned, TTCF could be
heat denatured prior to digestion to determine whether antigen unfolding would lead
to the generation of smaller digestion species detectable by mass spectrometric
analysis. In addition, the results in this study indicate that isotopic analysis alone can
not be used to identify peptides unambiguously. Therefore, in future experiments, the
sample should be split and MS/MS analysis carried out on peptides identified with a
'labelled' appearance to confirm their identity. To determine whether the 13C
technique is suitable for identifying naturally processed and presented peptides, the
13 • • •C labelling technique could be used to identify naturally processed and presented
peptides from an antigen that has already been studied in the way. This is currently
underway in the laboratory, with experiments being carried out to identify naturally
processed and presented peptides from a3 (IV) which has been previously identified
by biochemical techniques (Phelps et al., 1996).
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Analysis of lysosomal peptides has illuminated TTCF processing but cast no
light on the TTCF peptides that are presented to T cells. Unfortunately, there was
insufficient time to examine 13C-labelled TTCF-derived peptides eluted from HLA
class II molecules. However, the preliminary results from this project indicate that it
is very likely that application of the technique will allow identification of TTCF
peptides among peptides eluted from class II molecules of TTCF-pulsed APC.
Secondly, this approach would take into consideration the effects of MHC guided
processing upon antigen processing and T cell epitope production which the in-vitro
digestion system used in these experiments did not take into consideration (Sercarz et
al., 1993; Sercarz and Maverakis, 2003). In addition, in-vitro processing does not
take into consideration the influence of the B cell receptor which has been shown to
sculpt antigen processing of TTCF following internalisation of the antigen-receptor
complex (Watts et al., 1998). Therefore, a better system would be to use TTCF
specific B cell lines and isolate class II associated peptides following internalisation,
processing and presentation ofTTCF.
• • ... IT
Despite the discussed limitations, the C labelling technique shows great
potential in identifying naturally processed and presented T cell epitopes and could
be used to label potential vaccine candidates for the identification of T cell epitopes.
This may be desirable for antigens, such as the Por A protein from meningococcal
species, which have different immunogenicities between different strains. In
addition, it may be desirable to identify T cell epitopes that are conserved between
different species of bacteria, which is the case for the OMP F T cell epitope. For
these antigens, identifying immunogenic peptide sequences that are conserved
between different strains and that lead to the generation of a protective immune
response may prove beneficial in vaccine design. There are currently a number of
methods employed to identify potential vaccine candidates. The most recent advents
in this area are reverse vaccinology and 2D gel electrophoresis (Nilsson, 2002; Adu-
Bobie et al., 2003; Capecchi et al., 2004). If desired, potential vaccine candidates
identified by these methods could subsequently be 13C labelled and potential T cell
epitopes identified by examining peptides bound to class II molecules. Alternatively,
13 • •the C labelling technique could be used to label whole bacteria and then naturally
processed and presented T cell epitopes characterised in order to identify
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immunogenic bacterial proteins. The identification of naturally processed and
presented peptides from whole bacteria has only been carried to date for CD8+ T
cells. However, advances in mass spectrometric sensitivity may allow these
techniques to successfully be used to identify CD4+ T cell epitopes. This technique
would be favourable because it would identify proteins that are presented to T cells.
This would select out those proteins that are of immunological relevance rather than
identifying many proteins from bacteria that are not presented to T cells.
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Appendix 1
Sequences and molecular weights of the peptides used in HPLC development







Angiotensin I DRVYIHPFHL 1296.68
ACTH













G Glycine P Proline
A Alanine V Valine
L Leucine I Isoleucine
M Methionine c Cysteine
F Phenylalanine Y Cyrosine
W Tryptophan H Histidine
K Lysine R Arginine
Q Glutamine N Asparagine
E Glutamic acid D Aspartic acid
S Serine T Threonine
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Appendix 2
Sequences of the outer membrane proteins matched by experimental peptide
masses generated by trypsin digestion of protein bands 1,2 and 3
Omp A (band 3)
• MOWSE score: 107
• Number ofmass matches searched: 39
• Number ofmass values matched: 11
• Sequence coverage: 55%
Matched peptides shown in BOLD RED
1 MKKTAIAIAV ALAGFATVAQ AAPKDNTWYT GAKLGWSQYH DTGFINNNGP
51 THENQLGAGA FGGYQVNPYV GFEMGYDWLG RMPYKGSVEN GAYKAQGVQL
101 TAKLGYPITD DLDVYTRLGG MVWRADTKSN VYGKNHDTGV SPVFAGGVEY
151 AITPEIATRL EYQWTNNIGD AHTIGTRPDN GMLSLGVSYR FGQGEAAPW
201 APAPAPAPEV QTKHFTLKSD VLFTFNKATL KPEGQAALDQ LYSQLSNLDP
251 KDGSVWLGY TDRIGSDAYN QALSERRAQS WDYLISKGI PADKISARGM







4-33 2990.44 2990.59 K.TAIAIAVALAGFATVAQAAPKAAP
KDNTWYT GAK.L
25-33 1054.47 1054.47 K.DNTWYT GAK.L
104-117 1639.81 1639.81 K.LGYPITD DLDVYTR .L
118-124 817.45 817.43 R.LGG MVWR.A
135-159 2600.27 2600.29 K.NHDTGV SPVFAGGVEY
AITPEIATR.L
160-190 3477.61 3477.67 R.LEYQWTNNIGDAHTIGTRPDNGML
SLGVSYR.F
191-213 2231.15 2231.16 R.FGQGEAAPVVAPAPAPAPEVQTK.
H
228-251 2599.31 2599.35 K.ATL KPEGQAALDQ
LYSQLSNLDPK.D
252-263 1279.63 1279.64 K.DGSVVVLGY TDR.I
264-276 1422.67 1422.67 R.IGSDAYN QALSER.R
277-288 1377.77 1377.76 R.RAQS VVDYLISK.G
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Omp C (band 2)
• MOWSE score: 181
• Number ofmass matches searched: 53
• Number ofmass values matched: 18
• Sequence coverage: 66%
Matched peptides shown in BOLD RED
1 MKVKVLSLLV PALLVAGAAN AAEVYNKDGN KLDLYGKVDG LHYFSDDKSV
51 DGDQTYMRLG FKGETQVTDQ LTGYGQWEYQ IQGNSAENEN NSWTRVAFAG
101 LKFQDVGSFD YGRNYGWYD VTSWTDVLPE FGGDTYGSDN FMQQRGNGFA
151 TYRNTDFFGL VDGLNFAVQY QGKNGSVSEG MTNNGREALR QNGDGVGGSI
201 TYDYEGFGIG AAVSSSKRTD DQNSPLYIGN GDRAETYTGG LKYDANNIYL
251 AAQYTQTYNA TRVGSLGWAN KAQNFEAVAQ YQFDFGLRPS LAYLQSKGKN







28-37 1121.56 1121.57 K.DGNKLDLYGK.V
38-48 1294.59 1294.58 K.VDGLHYFSDDK.S
38-58 2447.08 2447.07 K.VDGLHYFSDDKSVDGDQTYMR.
L
49-58 1170.51 1170.51 K.SVDGDQTYMR.L
63-95 3802.67 3802.68 K.GETQVTDQLTGYGQWEYQIQGN
SAENENNSWTR.V
96-102 704.41 704.42 R.VAFAGLK.F
103-113 1289.55 1289.57 K.FQDVGSFDYGR.N
114-145 3659.65 3659.61 R.NYGWYDVTSWTDVLPEFGGDT
YGSDNFMQQR.G
146-153 884.41 884.41 R.GNGFATYR.N
154-173 2232.09 2232.09 R.NTDFFGLVDGLNFAVQYQGK.N
218-233 1819.81 1819.84 K.RTD DQNSPLYIGN GDR.A
219-233 1663.78 1663.74 R.TD DQNSPLYIGN GDR.A
243-262 2353.10 2353.10 K.YDANNIYLAAQYTQTYNATR.V
263-271 930.49 930.49 R.VGSLGWANK.A
272-297 2990.50 2990.49 K.AQNFEAVAQYQFDFGLRPSLAY
LQSK.G
300-307 841.50 841.48 K.NLGVINGR.N
317-328 1438.67 1438.68 K.YVDVGATYYFNK.N
338-348 1347.68 1347.68 K.INLLDDNQFTR.D
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Omp F (band 1)
• MOWSE score: 113
• Number ofmass values searched: 50
• Number ofmass values matched: 14
• Sequence coverage: 50%
Matched peptides shown in BOLD RED:
1 MMKRNILAVI VPALLVAGTA NAAEIYNKDG NKVDLYGKAV GLHYFSKGNG
51 ENSYGGNGDM TYARLGFKGE TQINSDLTGY GQWEYNFQGNNSEGADAQTG
101NKTRLAFAGL KYADVGSFDY GRNYGWYDA LGYTDMLPEFGGDTAYSDDF
151FVGRVGGVAT YRNSNFFGLV DGLNFAVQYL GKNERDTARRSNGDGVGGSI
201SYEYEGFGIV GAYGAADRTN LOEESSLGKG KKAEOWATGLKYDANNIYLA
251ANYGETRNAT PITNKFTNTS GFANKTODVL LVAOYOFDFGLRPSIAYTKS








29-38 1107.53 1107.56 K.DGNK VDLYGKA
39-47 1020.54 1020.54 K.AVGLHYFSK.G
48-64 1761.76 1761.70 K.GNGENSYGGNGDMTYAR.L
105-111 718.44 718.44 R.LAFAGLK.Y
112-122 1248.53 1248.54 K.YADVGSFDYGR.N
155-162 821.46 821.44 R.VGGVATYR.N
163-182 2202.13 2202.11 R.NSNFFGLV DGLNFAVQYLGK.N
191-218 2767.23 2767.24 R.SNGDGVGGSISYEYEGFGIV
GAYGAAR T
219-229 1204.55 1204.59 R.TNLOEESSLGK.G
232-241 1130.60 1130.61 K.KAEQWATGL K.Y
233-241 1002.51 1002.51 K.AEOWATGL K.Y
242-257 1846.86 1846.85 K.YDANNIYLAANYGETR.N
266-275 1085.51 1085.51 K.FTNTSGFANK.T
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